Search

Your search keyword '"Keane C"' showing total 1,097 results
Start Over Author "Keane C"
1,097 results on '"Keane C"'

1. Efficacy of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma in Patients with Concomitant Chronic Lymphocytic Leukemia

Author

Cass, S.H., Tobin, J.W.D., Seo, Y.D., Gener-Ricos, G., Keung, E.Z., Burton, E.M., Davies, M.A., McQuade, J.L., Lazar, A.J., Mason, R., Millward, M., Sandhu, S., Khoo, C., Warburton, L., Guerra, V., Haydon, A., Dearden, H., Menzies, A.M., Carlino, M., Smith, J.L., Mollee, P., Burgess, M., Mapp, S., Keane, C., Atkinson, V., Parikh, S.A., Markovic, S.N., Ding, W., Call, T.G., Hampel, P.J., Long, G.V., Wargo, J.A., and Ferrajoli, A.

Published
2023
Full Text
View/download PDF

3. EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity

Author

Gandhi, M.K., Hoang, T., Law, S.C., Brosda, S., O'Rourke, K., Tobin, J.W.D., Vari, F., Murigneux, V., Fink, L., Gunawardana, J., Gould, C., Oey, H., Bednarska, K., Delecluse, S., Trappe, R.U., Merida de Long, L., Sabdia, M.B., Bhagat, G., Hapgood, G., Blyth, E., Clancy, L., Wight, J., Hawkes, E., Rimsza, L.M., Maguire, A., Bojarczuk, K., Chapuy, B., and Keane, C.

Published
2021
Full Text
View/download PDF

5. Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study.

Author

Barraclough, A, Agrawal, S, Talaulikar, D, Chong, G, Yoo, E, Cheah, CY, Franco, N, Nguyen, B, Mutsando, H, Tahir, F, Trotman, J, Huang, J, Keane, C, Lincoln, M, Cochrane, T, Johnston, AM, Dickinson, M, Opat, S, McQuilten, ZK, Wood, EM, St George, G, Hawkes, EA, Barraclough, A, Agrawal, S, Talaulikar, D, Chong, G, Yoo, E, Cheah, CY, Franco, N, Nguyen, B, Mutsando, H, Tahir, F, Trotman, J, Huang, J, Keane, C, Lincoln, M, Cochrane, T, Johnston, AM, Dickinson, M, Opat, S, McQuilten, ZK, Wood, EM, St George, G, and Hawkes, EA

Abstract

Follicular Lymphoma (FL) treatment initiation is largely determined by tumor burden and symptoms. In the pre-rituximab era, the Group d'Etude des Lymphomes Folliculaires (GELF) developed widely adopted criteria to identify high tumor burden FL patients to harmonize clinical trial populations. The utilization of GELF criteria (GELFc) in routine therapeutic decision-making is poorly described. This multicenter retrospective study evaluated patterns of GELFc at presentation and GELFc utilization in therapeutic decision-making in newly diagnosed, advanced stage rituximab-era FL. Associations between GELFc, treatment given, and patient survival were analyzed in 300 eligible cases identified between 2002-2019. 163 (54%) had ≥1 GELFc at diagnosis. The presence or cumulative number of GELFc did not predict PFS in patients undergoing watch-and-wait (WW) or those receiving systemic treatment. Of interest, in patients with ≥1 GELFc, 16/163 (10%) underwent initial watch-and-wait (comprising 22% of the watchand- wait cohort). In those receiving systemic therapy +/- radiotherapy, 74/215 (34%) met no GELFc. Our data suggest clinicians are using adjunctive measures to make decisions regarding treatment initiation in a significant proportion of patients. By restricting FL clinical trial eligibility only to those meeting GELFc, reported outcomes may not be applicable to a significant proportion of patients treated in routine care settings.

Published
2024

6. The Effect of Different Weight Plate Widths (Bumper vs. Standard) on the Biomechanics of the Bench Press.

Author

Fiedler, Matthew J., Triplett, N. Travis, Hamilton, Keane C., Needle, Alan R., and van Werkhoven, Herman

Subjects
SKELETAL muscle physiology, BIOMECHANICS, CROSS-sectional method, RESEARCH funding, PECTORALIS muscle, DYNAMICS, DESCRIPTIVE statistics, STRENGTH training, RESISTANCE training, ELECTROMYOGRAPHY, DIGITAL video, ANALYSIS of variance, WEIGHT lifting, COMPARATIVE studies, MOTION capture (Human mechanics)
Abstract

Anecdotal evidence suggests that bumper plates impact lifts in powerlifting and weightlifting differently than standard cast iron plates, but whether biomechanical differences exist between lifts using bumper versus standard plates has not been investigated. Eleven resistance-trained subjects performed the bench press at 70, 80, and 90% of their 1 repetition maximum (1RM) while being blinded to whether they were lifting with bumper or standard plates. Motion data were captured by an 8-camera motion capture system, and electromyography (EMG) data were recorded for the anterior deltoid, pectoralis major, and triceps brachii. Repeated-measures analysis of variances showed a significant main weight effect for time under tension (p < 0.001), total work(p < 0.001), and muscle activity through EMG (across all muscles; p < 0.001) and a significant weight x joint interaction effect for average joint moment (p < 0.001) and peak joint moment (p < 0.001). However, there were no significant differences observed between the different weight plates for any of the measures. The main finding of the study suggests that there are no biomechanical differences between using bumper plates compared with standard plates during the bench press lift. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. Gene expression and spatial transcriptomic analysis of paired diagnosis and relapse DLBCL biopsies show a reduction in T cell infiltration and function at relapse

Author

Swain, F., primary, Burgess, M., additional, Kempe, S., additional, Sabdia, M., additional, Wight, J., additional, Hawkes, E., additional, Mutsando, H., additional, Talaulikar, D., additional, Merida de Long, L., additional, Hawula, Z., additional, Birch, S., additional, Wyche, P., additional, Gandhi, M. K., additional, and Keane, C., additional

Published
2023
Full Text
View/download PDF

10. Core outcome set for clinical studies of postoperative ileus after intestinal surgery

Author

Chapman, SJ, Lee, MJ, Blackwell, S, Arnott, R, ten Broek, RPG, Delaney, CP, Dudi-Venkata, NN, Fish, R, Hind, D, Jayne, DG, Mellor, K, Mishra, A, O'Grady, G, Sammour, T, Thorpe, G, Wells, C, Wolthuis, AM, Fearnhead, NS, Adegbola, S, Bagaglini, G, Bath, M, Bibby, N, Bisset, C, Blefari, N, Blencowe, NS, Bolton, W, Bulte, JP, Burch, J, Campanelli, M, Cano-Valderrama, O, Carver, J, Challand, C, Chan, S, Chandler, S, Clerc, D, Coe, P, Cox, D, Cross, KLR, Culkin, A, Cuthill, V, Daniels, S, Dawson, A, Dawson, L, Dixon, F, Downey, C, Drake, T, Duff, S, Dunning, G, Espin-Basany, E, Evans, MD, Fakhrul-Aldeen, M, Fisher, N, Fleetwood-Beresford, S, Gallo, G, Garoufalia, Z, George, R, Han, J, Harji, D, Harmston, R, Harris, DA, Mohammed, M, Helliwell, J, Hepburn, J, Herrod, P, Horwood, N, Keane, C, Kelly, S, Kroon, HM, Lonsdale, MDS, Major, G, Mattison, J, McLean, A Lawson, Millan, M, Limbert, S, McDermott, F, Mehraj, A, Moriarty, C, Moug, S, Murray, E, Naylor, M, Nepogodiev, D, Oliver, J, Pandey, D, Pata, F, Paterson, HM, Peckham-Cooper, A, Pellino, G, Pockney, P, Proctor, VK, Proud, D, Rew, V, Rutegard, M, Sahnan, K, Sayers, A, Siragusa, L, Smillie, RW, Spratt, J, Swain, D, Taylor, S, Tejedor, P, Thomas, O, Thompson, J, Tsimogiannis, K, Tuohey, D, Vissapragada, R, Younis, MU, Vaughan-Shaw, PG, Whyte, K, Wheelband, K, Williams, A, Yates, A, Young, R, Group, Tripartite Gastrointestinal Recovery Post-operative IIeus, Chapman, S J, Lee, M J, Blackwell, S, Arnott, R, ten Broek, R P G, Delaney, C P, Dudi-Venkata, N N, Fish, R, Hind, D, Jayne, D G, Mellor, K, Mishra, A, O’Grady, G, Sammour, T, Thorpe, G, Wells, C I, Wolthuis, A M, Fearnhead, N S, Adegbola, S, Bagaglini, G, Bath, M, Bibby, N, Bisset, C, Blefari, N, Blencowe, N S, Bolton, W, Bulte, J P, Burch, J, Campanelli, M, Cano-Valderrama, O, Carver, J, Challand, C, Chan, S, Chandler, S, Clerc, D, Coe, P, Cox, D, Cross, K L R, Culkin, A, Cuthill, V, Daniels, S, Dawson, A, Dawson, L, Dixon, F, Downey, C, Drake, T, Duff, S, Dunning, G, Espin-Basany, E, Evans, M D, Fakhrul-Aldeen, M, Fisher, N, Fleetwood-Beresford, S, Gallo, G, Garoufalia, Z, George, R, Han, J, Harji, D, Harmston, R, Harris, D A, Mohammed, M, Helliwell, J, Hepburn, J, Herrod, P, Horwood, N, Keane, C, Kelly, S, Kroon, H M, Lonsdale, M D S, Major, G, Mattison, J, Lawson McLean, A, Millan, M, Limbert, S, Mcdermott, F, Mehraj, A, Moriarty, C, Moug, S, Murray, E, Naylor, M, Nepogodiev, D, Oliver, J, Pandey, D, Pata, F, Paterson, H M, Peckham-Cooper, A, Pellino, G, Pockney, P, Proctor, V K, Proud, D, Rew, V, Rutegård, M, Sahnan, K, Sayers, A, Siragusa, L, Smillie, R W, Spratt, J, Swain, D, Taylor, S, Tejedor, P, Thomas, O, Thompson, J, Tsimogiannis, K, Tuohey, D, Vissapragada, R, Younis, M U, Vaughan-Shaw, P G, Whyte, K, Wheelband, K, Williams, A, Yates, A, and Young, R

Subjects
Science & Technology, Ileus, Postoperative Complications, Outcome Assessment, Health Care, Humans, Surgery, Postoperative Complication, Digestive System Surgical Procedure, Life Sciences & Biomedicine, Digestive System Surgical Procedures, Human
Abstract

ispartof: BRITISH JOURNAL OF SURGERY vol:109 issue:6 pages:493-496 ispartof: location:England status: published

Published
2022

13. Safety of Nonsteroidal Anti-inflammatory Drugs in Major Gastrointestinal Surgery: A Prospective, Multicenter Cohort Study

Author

Abbas, Z., Abburu, S., Abd Ghaffar, M. K., Abdelhadi, M., Abdikadir, H. R., Abdulmajid, A., Abid, H., Abid, A., Abuhussein, N., Abul, M. H., Acquaah, F., Acres, M., Adams, R., Adams, R. D., Adebayo, A. A., Adeleja, I., Adjei, H., Afzal, Z., Agarwal, V., Ahern, N., Ahmad, K., Ahmad, S., Ahmed, M., Ahmed, H., Ahmed, N., Ahmed, S., Ahmed, F., Ahn, J. S., Aidoo-Micah, G. E., Aildasani, L., Aithie, J. M., Akhtar, S., Ali, S., Ali, A., Ali, B., Ali, M., Ali, H., Alizadeh, M., Allan, C., Allen, J. L. Y., Allot, R., Al-Mousawi, A., Al-Obaedi, O., Al-Robeye, A., Amajuoyi, A., Amin, H., Amin, O., Amphlett, A. H., Anandarajah, C., Anderson, L., Anderson, L. B., Anderson, S. M., Ang, A., Angelov, S., Anilkumar, A., Anim-Addo, N., Ansari, N., Antoniou, I., Archer, C. H., Arif, T., Asbjoernsen, C. A., Ashfaq, U., Ashken, L., Ashraf, S. F., Ashraf, S., Ashton, A. J., Ashwood, J., Aslanyan, A., Asmadi, A., Assadullah, S., Atayi, A., Atraszkiewicz, B. A., Attalla, M., Austreng, L., Auyoung, E., Avery, P., Axelson, T., Aziz, H., Aziz, N., Baker, A. N., Bakewell, Z. R., Bakhsh, A., Balaji, S., Balian, V., Bamgbose, F. A., Barai, I., Barnes, J., Barrow, T. R., Barthorpe, A. E., Bartlett, J., Bartlett, R. D., Barton, E. C., Bassam, N., Bassett, J., Bassiony, S., Bath, M. F., Batho, A., Batt, E., Bazeer, H. Z., Beckett, J., Beecroft, S., Behar, N., Bell, N., Bell, L., Bell, A., Bemand, T. P., Bergara, T., Bernstein, I., Bethell, G. S., Bhanderi, S., Bhangu, A., Bhaskaran, G., Bhatt, N., Bhatti, M., Bhome, R., Bhudia, R., Bingham, G., Blege, H. K., Blessed, R., Bloomer, J., Bloomfield, T., Blore, C. D., Bolton, W., Bolton, L., Bonsu, S., Bookless, L. R., Bose, R., Botchey, S., Boulton, A. J., Boxall, N., Boyle, J., Braganza, L., Brathwaite-Shirley, C., Bravo, M., Brecher, J., Bremner, R. H., Brennan, C., Brennan, E., Brennan, K., Brent, G., Brewer, C. F., Brewster, O., Bright, M., Brown, D., Brown, E., Brown, F. S., Brown, E. J., Broyd, A., Brzyska, K., Buakuma, P., Buchan, A. M., Buckle, R. T., Bucko, A. M., Bulley, F., Bullman, L. M., Bullock, N. P., Burgess, A., Burke, J., Burke, D., Burke, E., Burney, L. J., Callan, R., Campbell, J., Canning, N., Canning, E., Cao, Y., Cardwell, A. E., Carr, L., Carr, R., Carroll, A. F., Carter, D., Carthew, L., Chamberlain, M., Chan, N., Chan, C., Chandan, N., Chapman, S. J., Charalambos, M. A., Charalambous, G., Charania, A., Charavanamuttu, V., Chaudhary, M., Chaudhry, F. I., Chaudhry, W. W., Cheema, H., Chen, J. H., Chen, X., Chen, M., Cheng, K., Chervenkoff, J., Cheskes, L., Cheung, F., Chew, L. S., Chew, L., Chhabra, A., Chhina, C., Chilima, C. P., Chillarge, G., Chilvers, N. J., Chin, H., Chin, R., Chisholm, E. G., Chitnis, A. R., Chiu, S. M., Chong, B. F., Chong, J., Choo, K. P., Chrastek, D., Chua, E. Y., Chung, A., Claireaux, H. A., Clark, I. J., Clarke, A. K., Cleere, J., Clement, K. D., Clesham, K., Coates, A., Cody, A., Cody, N., Coffey, D., Coffey, C. J., Coffin, J., Cole, S. J., Collier, H., Collins, A., Collins, D., Collinson, S., Cooper, G. E., Cooper, D., Copley, H. C., Copley, P. C., Cornish, E., Cotton, A., Coulson, R., Cox, S. E., Craig, A. R., Craig, E., Craig-McQuaide, A., Crewdson, J. A., Croall, A., Crozier, L., Cullen, C., Cullen, S., Culleton, G., Cumber, E., Cumber, E. M., Cumming, S., Cundy, O. J., Cunha, P., Curran, A., Cuthbert, G., Cymes, W., Daoub, A., Darr, S., Das, M., Datta, U., Davies, N., Davies, J., Davies, J. E., Davies, K., Davis-Hall, M., Dawar, R., Dawson, P. M., de Bernier, G. L., Deall, C., Dean, R., Dean, S., Dean, W., Dear, K., Deas, G., Debenham, R., Deekonda, P., Delport, A., Demetri, A. M., Dennis, Y. F., Dennis, R., Derbyshire, L., Devabalan, Y., Devlin, E., Dewdney, C. J., Dhanji, A., Dhar, M., Dhutia, A. J., Diaper, C., Dickson, J., Din, W., Dindyal, S., Dinsmore, L., Doan, L., Dobson, J., Dogra, T., Doherty, C., Dolaghan, M., Dolbec, K. S., Dorman, C., Drake, T. M., Drislane, C., Dube, P., Duffy, A., Duke, K., Duncumb, J. W., Dunn, C. E., Durr, A., Durrani, B., Dutt, S., Dyal, A. R., Dynes, K., Edison, M. A., Edozie, F., Egan, R. J., Egerton, C., Elangovan, V., Elf, D., Elkawafi, M., Elliott, L. E., Elseedawy, M., Empey, J., English, W., Entwisle, J. H., Eparh, K., Eragat, M., Eraifej, J., Esteve, L., Farmer, J. D., Fautz, T., Favero, N., Fawaz, A. S., Fergurson, P., Fern, J., Filby, J. J., Filipescu, T., Fitzgerald, J. E., FitzPatrick, D., Fleck, R., Fletcher, L., Fong, J., Forrest, P. R., Forte, B., Foster, N. L., Francescon, C. T., Frank, A. L., Fung, T. M. P., Gabriel, J., Gaffney, S., Galloway, E., Gandhi, K., Gardiner, N., Gardner, E., Gardner, H., Gatfield, W. A., Gauntlett, L., Gentry, S., George, D., Geraghty, J. M., Ghaffar, A., Gilbert, H., Giles, J. E., Gill, P., Gill, C. K., Girling, C., Glasbey, J. C., Glover, T. E., Goh, B., Goh, R. W., Gohil, K., Gokani, S., Gold, D., Golding, D. M., Goldsmith, T., Goodier, R., Goradia, H., Gouda, P., Gouldthrope, C., Govinden, S., Graham, C. J., Gratton, R., Gray, L., Greenhalgh, A. D., Greig, R. J., Griffin, E. J., Grossart, C. M., Grundy, L., Gulati, J., Gundogan, B., Gupta, V., Gwozdz, A. M., Siddiqui, Z. H., Hague, A., Hameed, M., Hanrahan, M., Haq, H., Harbhajan Singh, G. S., Hardie, J., Harding, F., Hardy, M. R., Harries, P., Harris, R. T., Harris, L. N., Harrison, E. M., Harrison, P. L. M., Hartley, J., Hartley, S., Harvey, J., Hassan, S., Hayat, M., Hayat, U., Hayes, J. D. B., He, A., Healy, L., Heathcote, E., Heer, R. S., Heminway, R., Henderson, I., Henderson, L. A., Henderson, C., Heneghan, H., Henson, A. D., Heppenstall-Harris, G., Herron, J., Heskin, J., Hester, E., Hewitt, C. M., Heywood, E. G., Hibberd, A., Hickling, S. L., Higgins, A., Higgs, L., Hill, A., Hindle Fisher, I., Hirani, S., Hirst, F., Hitchen, N., Ho, W., Ho, S., Hoban, K. A., Holliday, R. B. S., Holloway, C., Holmes, C., Holmes, M. J. V., Holton, P., Holyoak, H., Horne, L., Horst, C., Horth, D., Hoskins, T. C., Howells, L., Hu, L., Huang, H. C., Hudson-Phillips, S., Hughes, F., Hughes, B. A., Hughes, R. K., Hulley, K., Hung, G., Hurst, P. C., Husnoo, S. B., Hussain, N., Hussain, O., Ibrahim, I., Ibrahim, A., Ingham, R., Ingram, E., Iqbal, S., Iqbal, A., Isaac, A., Jackson, H. R., Jackson, S., Jacob, L., Jafree, D. J., Jaitley, A., Jalota, P., Jamal, N., Jathanna, N., Jawad, A. S., Jayakody, N., Jenkin, S. L., Jenvey, C., Jewell, P. D., Jhala, H., Jindal, A., Johnston, A., Johnston, J., Johnstone, M., Jordan, H. E. M., Joshi, K. R., Joshi, D., Joyce, H. L., Joyner, C., Jubainville, C. L., Jull, P., Kadicheeni, M., Kahar, A., Kalra, N., Kanabar, S., Kane, T., Karia, M., Karia, P., Karsan, R. B., Karunakaran, P., Kaushal, A., Kazmi, Z., Keane, P., Keane, C. P., Keane, N., Kee, J. Y., Keeling, R. E., Keelty, N., Keevil, H., Kelly, M., Kelly, M. E., Kelly, N., Kennedy, E. D., Kennedy, H. R., Kerai, A., Kerr, A. L., Khajuria, A., Khalid, H., Khan, T., Khan, M., Khan, S., Khan, U., Khan, A., Khangura, J., Khanijau, R., Khatri, C., Khattak, M., Khetarpal, A. A., Khokhar, H. A., Khonat, Z., Khonsari, P., Kiff, R., Kim, S., Kim, J. W., Kimani, L., King, M., Kishore, A., Kisyov, I., Kitt, H., Knight, C. L., Kong, C. Y., Kong, C., Kosasih, S. R., Koshy, R. M., Kotecha, D., Koumpa, F., Kow, K., Koysombat, K., Kreibich, A., Kretzmer, L., Kumar, A. N., Kumaran, G., Kwan, M. L., Kwang, P., Lakhani, M., Lakhani, S. M., Lakshmipathy, G., Lalor, P., Lamont, J., Lankage, C. M., Lavery, J., Lazenby, D., Ledsam, A., Lee, A. H. Y., Lee, S., Lees, D. M., Lek, C., Leong, S., Leslie, K. E., Leung, W., Lewis, T., Li, N., Li, M. M., Liew, Y., Liew, W., Lim, K., Lim, J., Lim, D., Lim, A. E., Lim, S. J., Lim, S., Lim, E., Linton, A., Liu, S., Liu, C., Livesey, A., Lo, T., Lockey, J. W., Logan, A. E., Loke, W., Long, F., Lopes, S., Lotfallah, A., Lou, C. N., Loughran, D., Loveday, J., Low, J. Y. L., Lu, Q., Lua Boon Xuan, J., de Carvalho, J. Lucas, Luhishi, A., Luk, C. Y., Lunawat, S., Lwin, K. N., Lykoudis, P. M., Lynch, A. S., Lynne, S., Lyons, R., Maamari, R., MacAskill, A., MacDonald, J., Mackin, S., Maclennan, D., Mah, J., Mahboob, S., Maheswaran, Y., Mahmood, J., Majid, S., Major, C., Malaj, M., Malik, A., Mallick, S., Malys, M. K., Manson, R., Mansoor, S., Maple, N., Marchal, S. T., Markham, R. M., Marsden, M., Marsh, A., Marshall, D. C., Martin, A. L., Martin, R., Maru, D., Mason, J. D., Masood, M., Mastan, A., Matheson, J., Matthams, J., Matthews, B. W., Matthews, J. H., Maxwell-Armstrong, C., Mazan, K., Mazumdar, E., McAleer, S., McAleer, E., McAllister, R., McAuley, D., McBride, A., McCabe, G., McCance, E., McCann, M., McClymont, L. F., McCormack, D. R., McCrann, C., McDowell, M., McEnhill, P. M., McFarlane, H., McGalliard, R. J., McGarrigle, C., McGarvie, S., Mcgenity, C., McGowan, C., McGrath, A., McGregor, R. J., McIntyre, C. J., Mckean, E., McKelvey, L. L., McKerr, C. N., McKevitt, K. L., McLaughin, C., McLean, R. C., McLure, S. W., McMenamin, M., McMullan, R., McNamee, L., McRobbie, H. D., Meek, J., Mehdi, A., Mehta, J. K., Menon, A., Mian, A., Mills, E. D., Mills, M., Mills, H., Milne, S., Minhas, M., Miranda, B. H., Mirdavoudi, V., Mirza, M., Mishra, A., Mistry, S., Mistry, B. D., Mitchell, H., Mitha, N., Mithrakumar, P., Mitrasinovic, S., Mittapalli, D., Mogan, Y. P., Mohamud, M., Mohan, M., Mohan, K., Mohite, A., Momoh, Z., Moody, N., Moon, R. D. C., Moradzadeh, J., Morgan, F., Morgan, C., Morley, R., Morris, F., Morris, S., Morrison, P., Morrison, C. J., Mortimer, A., Murkin, C., Murphy, L., Murray, S. E., Murtaza, A., Mushtaq, J., Nachiappan, R., Nadanakumaran, K., Naqib, S., Narain, A., Naran, P., Narang, Y., Narayan, P., Narramore, R., Narwani, V., Navayogaarajah, V., Naveed, H., Nayee, H., Nehikhare, I., Nelaj, S., Neo, Y. N., Neophytou, C., Nepogodiev, D., Nesargikar, P. N., Ng, K., Ng, J. C. K., Ng, G. S., Ng, J. Q., Ng, A. Y. L., Ng, S., Ng, L., Nicholls, K., Nixon, G., Norris, J. M., North, A. S., Norton, J., Ntala, C., O’Bryan, M., O’Carroll, O., O’Connell, C., O’Connor, A., O’Connor, S., O’Flynn, L. D., O’Kane, A., O’Loughlin, R. A., O’Neill, S., O’Neill, E. M., O’Reilly, D., O’Sullivan, D. A., O’Sullivan, K., Obute, R. D., Odeleye, A., Omar, A., Omara, S., Omer, H. M., Ong, K. K., Oremule, B., Osei-Kuffour, D., Osman, S., Owasil, R., Owczarek, S., Williams, R. P., Paine, H. R., Pal, S., Palkhi, E., Palmer, C., Pandey, A., Pandey, G., Paraoan, V., Park, J. H., Parker, O., Parker, J., Parkin, J., Parsons, S., Parthiban, S., Patel, P., Patel, M., Patel, T., Patel, S., Patel, N., Patel, J. B., Patel, V., Patel, B. Y., Patel, B., Patel, B. A., Patel, K., Paul, J., Pearce, J., Pearse, R. J., Peck, F. S., Perera, M., Pericleous, A., Peroos, S., Peters, M., Petra, H., Petrarca, M., Pezas, T. P., Phan, P. N., Phillips, C., Pickard, J., Pinto, R., Piquet, A., Pitts-Tucker, T., Pizzolato, A., Player, C., Ponweera, A., Poo, S. X., Pope, S., Prabhudesai, A., Prakash, E., Preece, R., Prest-Smith, J., Priestland, R., Prys-Jones, O., Ptacek, I. B., Puan, L., Punj, R., Punjabi, N., Qamar, M. A., Qureshi, S., Qureshi, U., Qureshi, A., Rabinthiran, S., Radotra, A., Rafiq, N. M., Raghuvir, V., Raghvani, T., Rajan, N., Raji, K., Raman, K. P., Ramjeeawon, N., Ramnarine, A., Rampal, R., Ramsay, N., Ramtoola, T., Rangan, T., Rangedara, A., Raphael, M., Rashid, S., Rashid, M., Rasiah, M. G., Ratnakumaran, R., Rattan, G., Ratu, S. G., Raut, P., Reakes, T., Redgrave, N. A., Reed, A., Reeder, C., Reehal, R. S., Rees, C., Reeves, T., Reid, N. B., Reid, R., Reid, K. G., Remedios, J., Rhema, I. A., Rinkoff, S., Roberts, E. J., Roberts, A. W., Roberts, H. F., Roberts, C., Robertson, K. L., Robertson, V., Robertson, D. T., Robinson, M., Robinson, C., Robson, J., Rocke, A. S., Rogers, J. E., Rogers, S., Rojoa, D., Rookes, C. W., Rosen O’Sullivan, H., Ross, T., Ross, H., Rothwell, L., Roy, C. S. D., Ruiz, E. M., Russell, G., Ryan, M., Sabine, L. M., Sagar, R., Sagmeister, M., Sahathevan, A., Sait, M. S., Sajjad, U., Salam, G. J., Sale, T., Salem, M., Salih, A. E., Salmon, D., Sanders, J. A., Sandhu, K. K., Sandhu, S., Sangal, P., Sarvanandan, T., Sarwar, S., Sasapu, K., Satterthwaite, L., Schulz, T. M., Scotcher, S. E., Seager, E., Seedat, M., Segall, E., Sellathurai, J., Selvachandran, H., Semana, A. D., Semnani, S. A., Semple, E., Seneviratne, N., Sethi, R. K., Shafi, A. M. A., Shafiq, N. M., Shah, A., Shah, J. P., Shah, R., Shah, S., Shaheen, H., Shahid, S., Shahidi, S., Shakweh, E., Shanahan, D., Sharifpour, M., Shatkar, V., Shaunak, R., Sheldon, A., Shepherd, R., Shepherd, P., Sherif, M. A., Sherliker, G. X. J., Sheth, S., Shoa, M., Shufflebotham, H., Shuker, B. A., Shukla, A., Shumon, S., Shurovi, B. N., Shuttleworth, R. H., Siddiqui, M., Sii, S., Sim, N. K., Sim, P., Sim, D., Simpson, R., Simpson, A., Singagireson, S., Singh, B., Singh, K., Singh, R., Singh, S., Sinha, Y., Sirakaya, M., Sitta, O., Slade, R., Smith, N., Smith, D. N. E., Smith, A. C. D., Sng, S., Soo, Y. H., Soon, W. C., Sorah, T., Spence, O., Spencer, T., Springford, L. R., Sreh, A., Srikantharajah, M., Sritharan, P., Stanger, S. A., Stanley, G. H., Stather, P. W., Steel, M., Stein, J., Stevens, S., Stewart, G. E., Stezaker, S., Stoddart, M. T., Stokes, S., Stone, E. J., Stott, G. D., Strange, E., Street, A. N., Sukkari, M., Sukumar, S., Suleman, Y. N., Sullivan, J. A. L., Sun, E., Sundar-Singh, M., Suresh, S., Suresh, R. S., Syeed, J. A., Sykes, M. C., Szczap, A., Tahir, M., Tahmina, A., Tai, A., Talukdar, S. S., Tan, Y. H., Tan, R., Tan, E. T., Tan, D., Tan, Y., Tan, S., Tan, E. S. M., Tay, A. Y., Tayeh, S., Tear, A. K., Telfer, R., Teng, V., Teoh, P. J., Thacoor, A., Thakker, C. E., Thakur, H., Tharakan, R. G., Tharmachandirar, T., Theodoreson, M. D., Theodoropoulou, K., Thethi, R., Thevathasan, A. A., Thirumal, V., Thomas, G., Thomas, D., Thompson, O. D., Thompson, J. D., Tilston, T. W., Toale, C., Toh, C., Toner, E., Tongo, F., Tonkins, M., Topham, C., Torlot, G. E., Torrance, H. D., Trail, M., Traynor, B. P., Trecarten, S., Trimble, A., Trist, A. J., Tsui, A. Y., Tung, L., Turaga, S., Turley, H., Turnbull, J. A., Turner, L., Turner, M., Turner, E. J. H., Turner, J., Ungcharoen, N., Uppal, E., Valli, A., Vanmali, P., Varley, R., Varma, R. K., Varma, D., Varma, N., Vaughan, R., Venn, M., Ventre, C. M., Verma, K., Verma, S., Vernon, O. K., Vithanage, N. A., Vivekanantham, S., Wadanamby, S., Waldron, R. M., Walford, R. A., Wali, A., Wall, C., Walsh, S. L., Wan, J. C., Wang, S., Wang, A., Ward, N., Ward, T., Ward, A. E., Warren, N., Warwick, H. L., Watson, N., Watson, R. P., Weaver, R., Webb, E., Weinberg, D., Wells, M., Weston, C., Wetherall, N., Whacha, C., Whatling, E. A., Whewell, H., White, A., White, C. J., White, U., Whitehurst, K., Whitham, R. D. J., Whittingham, H., Wijesekera, M., Wild, J. R. L., Wilkinson, D., Williams, M., Williams, M. R., Williams, P., Wills, J., Wilson, H. C. P., Wilson, H., Wilson, R., Wiltshire, J. J., Winarski, A., Wing, V. C., Wingfield, L. R., Winslow, F., Woin, E., Wong, V., Wong, E., Wood, A. D., Woodcock, N., Woodward, H., Woon, E., Wright, A., Wright, E. V., Wye, J., Wylam, D., Wylie, J., Wynell-Mayow, W. M., Xiao, C., Xu, G. X., Xylas, D., Yan, A., Yang, T., Yates, J. A., Yener, A., Yim, N., Yoganathan, S., Yong, C. S., Yong, N., Yousif, A., Yow, L., Yuen, R., Zegeye, M. I., Zhao, J., Ziff, O., Ziprin, P., Zuhair, M., and STARSurg Collaborative

Published
2017
Full Text
View/download PDF

15. Probing matter at Gbar pressures at the NIF

Author

Kritcher, A.L., Döppner, T., Swift, D., Hawreliak, J., Collins, G., Nilsen, J., Bachmann, B., Dewald, E., Strozzi, D., Felker, S., Landen, O.L., Jones, O., Thomas, C., Hammer, J., Keane, C., Lee, H.J., Glenzer, S.H., Rothman, S., Chapman, D., Kraus, D., Neumayer, P., and Falcone, R.W.

Published
2014
Full Text
View/download PDF

16. P1087: FAVEZELIMAB (ANTI–LAG-3) AND PEMBROLIZUMAB CO-BLOCKADE IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA WHO PROGRESSED AFTER ANTI–PD-1 THERAPY: AN OPEN-LABEL PHASE 1/2 STUDY

Author

Herrera, A. F., primary, Lavie, D., additional, Johnson, N. A., additional, Avigdor, A., additional, Borchmann, P., additional, Andreadis, C., additional, Bazargan, A., additional, Gregory, G., additional, Keane, C., additional, Inna, T., additional, Vucinic, V., additional, Zinzani, P. L., additional, Zhang, H., additional, Pillai, P., additional, Marinello, P., additional, and Timmerman, J., additional

Published
2022
Full Text
View/download PDF

17. P1086: FAVEZELIMAB (ANTI–LAG-3) AND PEMBROLIZUMAB CO-BLOCKADE IN ANTI–PD-1–NAIVE PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA: AN OPEN-LABEL PHASE 1/2 STUDY

Author

Gregory, G., primary, Timmerman, J., additional, Lavie, D., additional, Borchmann, P., additional, Herrera, A. F., additional, Minuk, L., additional, Vucinic, V., additional, Armand, P., additional, Avigdor, A., additional, Gasiorowski, R., additional, Herishanu, Y., additional, Keane, C., additional, Kuruvilla, J., additional, Palcza, J., additional, Pillai, P., additional, Marinello, P., additional, and Johnson, N. A., additional

Published
2022
Full Text
View/download PDF

18. Favezelimab (anti-LAG-3) plus pembrolizumab in patients with relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL) after anti-PD-1 treatment: An open-label phase 1/2 study.

Author

Timmerman J., Lavie D., Johnson N.A., Avigdor A., Borchmann P., Andreadis C., Bazargan A., Gregory G., Keane C., Inna T., Vucinic V., Luigi Zinzani P., Zhang H., Pillai P., Marinello P., Herrera A.F., Timmerman J., Lavie D., Johnson N.A., Avigdor A., Borchmann P., Andreadis C., Bazargan A., Gregory G., Keane C., Inna T., Vucinic V., Luigi Zinzani P., Zhang H., Pillai P., Marinello P., and Herrera A.F.

Abstract

Background: PD-1 inhibitors are a standard of care for R/R cHL but optimal therapy after anti-PD-1 therapy failure is yet to be defined. LAG-3/PD-1 coblockade has demonstrated antitumor activity in preclinical models. This multicohort phase 1/2 study (NCT03598608) evaluated the safety and efficacy of favezelimab (MK-4280), a humanized IgG4 LAG-3 inhibitor, plus the PD-1 inhibitor pembrolizumab (pembro) in pts with R/R hematologic malignancies. Cohort 2 focused on pts with R/R cHL refractory to anti-PD-1 therapy. Method(s): This study included a safety lead-in phase (part 1) to determine recommended phase 2 dose (RP2D) followed by a dose-expansion phase (part 2). Eligible pts in cohort 2 had R/R cHL, relapsed after or were ineligible for autologous stem cell transplantation (ASCT), and progressed after >=2 doses of anti-PD-1 therapy (within 12 weeks of last dose). In part 1, pts from all cohorts received pembro IV 200 mg Q3W and favezelimab IV 200 mg or 800 mg Q3W. Dose-finding based on occurrence of dose-limiting toxicities (DLT) was determined using an mTPI design. In part 2, pts received pembro + favezelimab at the established RP2D for up to 35 cycles. Primary end point was safety. Secondary end point was ORR. DOR, PFS, and OS were exploratory. Result(s): Only 1 DLT (autoimmune hepatitis [grade 4]) was observed among the first 6 pts from all cohorts in part 1 at the favezelimab 200 mg dose; thus, the dose was escalated to 800 mg. No DLTs were observed in 15 additional pts at the 800 mg dose. Favezelimab RP2D was defined as 800 mg Q3W + pembro 200 mg Q3W. In cohort 2, 33 pts were enrolled; median age was 37 yrs, 64% had ECOG PS 0, and 94% had >=4 prior lines of therapy. After a median follow-up of 16.5 mo, ORR for pts receiving favezelimab 800 mg (n = 29) was 31% (95% CI, 15-51; CR, 2 [7%]; PR, 7 [24%]); 66% of responders had an anti-PD-1-based regimen as most recent line of therapy at study entry. 23 of 29 pts (79%) had reduction from baseline in target lesions. M

Published
2022

19. Favezelimab (anti-LAG-3) plus pembrolizumab in patients with anti-PD-1-naive relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL): An open-label phase 1/2 study.

Author

Johnson N.A., Lavie D., Borchmann P., Gregory G., Herrera A.F., Minuk L., Vucinic V., Armand P., Avigdor A., Gasiorowski R., Herishanu Y., Keane C., Kuruvilla J., Palcza J., Pillai P., Marinello P., Timmerman J., Johnson N.A., Lavie D., Borchmann P., Gregory G., Herrera A.F., Minuk L., Vucinic V., Armand P., Avigdor A., Gasiorowski R., Herishanu Y., Keane C., Kuruvilla J., Palcza J., Pillai P., Marinello P., and Timmerman J.

Abstract

Background: PD-1 inhibitors are a standard of care in pts with R/R cHL but new approaches are still needed to deepen and lengthen responses. Dual blockade of PD-1 and LAG-3 has demonstrated antitumor activity in preclinical models. The multicohort phase 1/2 MK-4280-003 study (NCT03598608) evaluated the safety and efficacy of favezelimab (MK-4280), a humanized IgG4 LAG-3 inhibitor, plus pembrolizumab (pembro; a PD-1 inhibitor) in pts with R/R hematologic malignancies. This analysis focused on anti-PD-1-naive pts with R/R cHL (cohort 1). Method(s): This study included a safety lead-in phase (part 1) to determine the recommended phase 2 dose (RP2D) followed by a dose-expansion phase (part 2). Eligible pts in cohort 1 must have R/R cHL after autologous stem cell transplantation (ASCT) or be ineligible for ASCT and have had no prior anti-PD-1 therapy. In part 1, patients from all cohorts received pembro IV 200 mg Q3W and favezelimab IV 200 mg or 800 mg Q3W. Dose escalation followed the mTPI design. In part 2, pts received pembro + favezelimab at the established RP2D for up to 35 cycles. Primary end point was safety. Secondary end point was ORR. DOR, PFS, and OS were exploratory end points. Result(s): Only 1 dose-limiting toxicity (DLT; autoimmune hepatitis [grade 4]) was identified among the first 6 pts from all cohorts in part 1 at the favezelimab 200 mg dose; thus, the dose was escalated to 800 mg. No DLTs were observed in the 15 additional pts treated at the 800 mg dose. The RP2D for the combination was defined as 800 mg Q3W + pembro 200 mg Q3W. In cohort 1, 30 pts were enrolled; median age was 40 years, 53% had ECOG PS 0, and 80% had <=3 prior lines of therapy. After a median follow-up of 13.5 mo, ORR for cohort 1 was 73% (95% CI, 54-88; CR, 7 pts [23%]; PR, 15 pts [50%]). 28 of 30 pts (93%) had reduction from baseline in target lesions. Median DOR was not reached (NR; 95% CI, 0+ to 23+ mo); 6 pts (51%) had response >=12 mo. Median PFS was 19 mo (95% CI, 8-NR); 12-mo

Published
2022

20. Improving outcomes for patients with lymphoma: design and development of the Australian and New Zealand Lymphoma and Related Diseases Registry

Author

Anderson, MA, Berkahn, L, Cheah, C, Dickinson, M, Gandhi, MK, Giri, P, Hawkes, EA, Johnston, A, Keane, C, McQuilten, ZK, Mulligan, SP, Opat, S, Talaulikar, D, Trotman, J, Williams, J, Wood, EM, Armytage, T, Barraclough, A, Carradice, D, Chong, G, Cochrane, T, Hamad, N, Ku, M, Lee, D, Morgan, S, Mutsando, H, Narayana, M, Prince, HM, Ratnasingam, S, Wight, J, Badoux, X, Cull, G, Kuss, B, Marlton, P, Tam, C, Casan, J, Cushion, T, Tedjaseputra, A, Birch, S, Brown, C, Ellis, D, Harvey, Y, Hitchins, S, Jain, S, Jessup, P, Juneja, S, Kearney, D, Kumar, B, Lade, S, Lee, K, Leslie, C, Long, E, Morey, A, Nath, L, Norris, D, Parker, A, Parry, J, Chen, FP-Y, Chung, E, Morison, J, Rowsell, L, St George, G, Thu, C, Waters, N, Wellard, C, Zheng, M, Anderson, MA, Berkahn, L, Cheah, C, Dickinson, M, Gandhi, MK, Giri, P, Hawkes, EA, Johnston, A, Keane, C, McQuilten, ZK, Mulligan, SP, Opat, S, Talaulikar, D, Trotman, J, Williams, J, Wood, EM, Armytage, T, Barraclough, A, Carradice, D, Chong, G, Cochrane, T, Hamad, N, Ku, M, Lee, D, Morgan, S, Mutsando, H, Narayana, M, Prince, HM, Ratnasingam, S, Wight, J, Badoux, X, Cull, G, Kuss, B, Marlton, P, Tam, C, Casan, J, Cushion, T, Tedjaseputra, A, Birch, S, Brown, C, Ellis, D, Harvey, Y, Hitchins, S, Jain, S, Jessup, P, Juneja, S, Kearney, D, Kumar, B, Lade, S, Lee, K, Leslie, C, Long, E, Morey, A, Nath, L, Norris, D, Parker, A, Parry, J, Chen, FP-Y, Chung, E, Morison, J, Rowsell, L, St George, G, Thu, C, Waters, N, Wellard, C, and Zheng, M

Abstract

BACKGROUND: Lymphoma is a malignancy of lymphocytes and lymphoid tissues comprising a heterogeneous group of diseases, with up to 80 entities now described. Lymphoma is the 6th most common cancer in Australia, affecting patients of all ages, with rising incidence rates. With the proliferation of efficacious novel agents, therapeutic strategies are increasingly diverse and survival is improving. There is a clear need for contemporary robust and detailed data on diagnostic, investigational and management strategies for this disease in Australia, New Zealand and worldwide, to inform and benchmark local and international standards of care. Clinical quality registries can provide these data, and support development of strategies to address variations in management, including serving as platforms for clinical trials and other research activities. The Lymphoma and Related Diseases Registry (LaRDR) was developed to capture details of patient demographics, disease characteristics, and management throughout their disease course and therapy and to develop outcome benchmarks nationally and internationally for lymphoma. This report describes the aims, development and implementation of the LaRDR, as well as challenges addressed in the process. METHODS: The LaRDR was established in 2016 as a multicentre, collaborative project at sites across Australia with a secure online database which collects prospective data on patients with a new diagnosis of lymphoma or chronic lymphocytic leukaemia (CLL). LaRDR development required multidisciplinary participation including specialist haematology, information technology, and biostatistical support, as well as secure funding. Here we describe the database development, data entry, ethics approval process, registry governance and support for participating sites and the coordinating centre. RESULTS: To date more than 5,300 patients have been enrolled from 28 sites in Australia and New Zealand. Multiple challenges arose during the development, wh

Published
2022

22. Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment

Author

Abu-Shawareb, H, Acree, R, Adams, P, Adams, J, Addis, B, Aden, R, Adrian, P, Afeyan, BB, Aggleton, M, Aghaian, L, Aguirre, A, Aikens, D, Akre, J, Albert, F, Albrecht, M, Albright, BJ, Albritton, J, Alcala, J, Alday, C, Alessi, DA, Alexander, N, Alfonso, J, Alfonso, N, Alger, E, Ali, SJ, Ali, ZA, Alley, WE, Amala, P, Amendt, PA, Amick, P, Ammula, S, Amorin, C, Ampleford, DJ, Anderson, RW, Anklam, T, Antipa, N, Appelbe, B, Aracne-Ruddle, C, Araya, E, Arend, M, Arnold, P, Arnold, T, Asay, J, Atherton, LJ, Atkinson, D, Atkinson, R, Auerbach, JM, Austin, B, Auyang, L, Awwal, AS, Ayers, J, Ayers, S, Ayers, T, Azevedo, S, Bachmann, B, Back, CA, Bae, J, Bailey, DS, Bailey, J, Baisden, T, Baker, KL, Baldis, H, Barber, D, Barberis, M, Barker, D, Barnes, A, Barnes, CW, Barrios, MA, Barty, C, Bass, I, Batha, SH, Baxamusa, SH, Bazan, G, Beagle, JK, Beale, R, Beck, BR, Beck, JB, Bedzyk, M, Beeler, RG, Behrendt, W, Belk, L, Bell, P, Belyaev, M, Benage, JF, Bennett, G, Benedetti, LR, Benedict, LX, Berger, R, Bernat, T, Bernstein, LA, Berry, B, Bertolini, L, Besenbruch, G, Betcher, J, Bettenhausen, R, Betti, R, Bezzerides, B, Bhandarkar, SD, Bickel, R, Biener, J, Biesiada, T, Bigelow, K, Bigelow-Granillo, J, Bigman, V, Bionta, RM, Birge, NW, Bitter, M, Black, AC, Bleile, R, Bleuel, DL, Bliss, E, Blue, B, Boehly, T, Boehm, K, Boley, CD, Bonanno, R, Bond, EJ, Bond, T, Bonino, MJ, Borden, M, Bourgade, J-L, Bousquet, J, Bowers, J, Bowers, M, Boyd, R, Bozek, A, Bradley, DK, Bradley, KS, Bradley, PA, Bradley, L, Brannon, L, Brantley, PS, Braun, D, Braun, T, Brienza-Larsen, K, Briggs, TM, Britten, J, Brooks, ED, Browning, D, Bruhn, MW, Brunner, TA, Bruns, H, Brunton, G, Bryant, B, Buczek, T, Bude, J, Buitano, L, Burkhart, S, Burmark, J, Burnham, A, Burr, R, Busby, LE, Butlin, B, Cabeltis, R, Cable, M, Cabot, WH, Cagadas, B, Caggiano, J, Cahayag, R, Caldwell, SE, Calkins, S, Callahan, DA, Calleja-Aguirre, J, Camara, L, Camp, D, Campbell, EM, Campbell, JH, Carey, B, Carey, R, Carlisle, K, Carlson, L, Carman, L, Carmichael, J, Carpenter, A, Carr, C, Carrera, JA, Casavant, D, Casey, A, Casey, DT, Castillo, A, Castillo, E, Castor, JI, Castro, C, Caughey, W, Cavitt, R, Celeste, J, Celliers, PM, Cerjan, C, Chandler, G, Chang, B, Chang, C, Chang, J, Chang, L, Chapman, R, Chapman, T, Chase, L, Chen, H, Chen, K, Chen, L-Y, Cheng, B, Chittenden, J, Choate, C, Chou, J, Chrien, RE, Chrisp, M, Christensen, K, Christensen, M, Christopherson, AR, Chung, M, Church, JA, Clark, A, Clark, DS, Clark, K, Clark, R, Claus, L, Cline, B, Cline, JA, Cobble, JA, Cochrane, K, Cohen, B, Cohen, S, Collette, MR, Collins, G, Collins, LA, Collins, TJB, Conder, A, Conrad, B, Conyers, M, Cook, AW, Cook, D, Cook, R, Cooley, JC, Cooper, G, Cope, T, Copeland, SR, Coppari, F, Cortez, J, Cox, J, Crandall, DH, Crane, J, Craxton, RS, Cray, M, Crilly, A, Crippen, JW, Cross, D, Cuneo, M, Cuotts, G, Czajka, CE, Czechowicz, D, Daly, T, Danforth, P, Darbee, R, Darlington, B, Datte, P, Dauffy, L, Davalos, G, Davidovits, S, Davis, P, Davis, J, Dawson, S, Day, RD, Day, TH, Dayton, M, Deck, C, Decker, C, Deeney, C, DeFriend, KA, Deis, G, Delamater, ND, Delettrez, JA, Demaret, R, Demos, S, Dempsey, SM, Desjardin, R, Desjardins, T, Desjarlais, MP, Dewald, EL, DeYoreo, J, Diaz, S, Dimonte, G, Dittrich, TR, Divol, L, Dixit, SN, Dixon, J, Dodd, ES, Dolan, D, Donovan, A, Donovan, M, Döppner, T, Dorrer, C, Dorsano, N, Douglas, MR, Dow, D, Downie, J, Downing, E, Dozieres, M, Draggoo, V, Drake, D, Drake, RP, Drake, T, Dreifuerst, G, DuBois, DF, DuBois, PF, Dunham, G, Dylla-Spears, R, Dymoke-Bradshaw, AKL, Dzenitis, B, Ebbers, C, Eckart, M, Eddinger, S, Eder, D, Edgell, D, Edwards, MJ, Efthimion, P, Eggert, JH, Ehrlich, B, Ehrmann, P, Elhadj, S, Ellerbee, C, Elliott, NS, Ellison, CL, Elsner, F, Emerich, M, Engelhorn, K, England, T, English, E, Epperson, P, Epstein, R, Erbert, G, Erickson, MA, Erskine, DJ, Erlandson, A, Espinosa, RJ, Estes, C, Estabrook, KG, Evans, S, Fabyan, A, Fair, J, Fallejo, R, Farmer, N, Farmer, WA, Farrell, M, Fatherley, VE, Fedorov, M, Feigenbaum, E, Feit, M, Ferguson, W, Fernandez, JC, Fernandez-Panella, A, Fess, S, Field, JE, Filip, CV, Fincke, JR, Finn, T, Finnegan, SM, Finucane, RG, Fischer, M, Fisher, A, Fisher, J, Fishler, B, Fittinghoff, D, Fitzsimmons, P, Flegel, M, Flippo, KA, Florio, J, Folta, J, Folta, P, Foreman, LR, Forrest, C, Forsman, A, Fooks, J, Foord, M, Fortner, R, Fournier, K, Fratanduono, DE, Frazier, N, Frazier, T, Frederick, C, Freeman, MS, Frenje, J, Frey, D, Frieders, G, Friedrich, S, Froula, DH, Fry, J, Fuller, T, Gaffney, J, Gales, S, Le Galloudec, B, Le Galloudec, KK, Gambhir, A, Gao, L, Garbett, WJ, Garcia, A, Gates, C, Gaut, E, Gauthier, P, Gavin, Z, Gaylord, J, Geissel, M, Génin, F, Georgeson, J, Geppert-Kleinrath, H, Geppert-Kleinrath, V, Gharibyan, N, Gibson, J, Gibson, C, Giraldez, E, Glebov, V, Glendinning, SG, Glenn, S, Glenzer, SH, Goade, S, Gobby, PL, Goldman, SR, Golick, B, Gomez, M, Goncharov, V, Goodin, D, Grabowski, P, Grafil, E, Graham, P, Grandy, J, Grasz, E, Graziani, F, Greenman, G, Greenough, JA, Greenwood, A, Gregori, G, Green, T, Griego, JR, Grim, GP, Grondalski, J, Gross, S, Guckian, J, Guler, N, Gunney, B, Guss, G, Haan, S, Hackbarth, J, Hackel, L, Hackel, R, Haefner, C, Hagmann, C, Hahn, KD, Hahn, S, Haid, BJ, Haines, BM, Hall, BM, Hall, C, Hall, GN, Hamamoto, M, Hamel, S, Hamilton, CE, Hammel, BA, Hammer, JH, Hampton, G, Hamza, A, Handler, A, Hansen, S, Hanson, D, Haque, R, Harding, D, Harding, E, Hares, JD, Harris, DB, Harte, JA, Hartouni, EP, Hatarik, R, Hatchett, S, Hauer, AA, Havre, M, Hawley, R, Hayes, J, Hayes, S, Hayes-Sterbenz, A, Haynam, CA, Haynes, DA, Headley, D, Heal, A, Heebner, JE, Heerey, S, Heestand, GM, Heeter, R, Hein, N, Heinbockel, C, Hendricks, C, Henesian, M, Heninger, J, Henrikson, J, Henry, EA, Herbold, EB, Hermann, MR, Hermes, G, Hernandez, JE, Hernandez, VJ, Herrmann, MC, Herrmann, HW, Herrera, OD, Hewett, D, Hibbard, R, Hicks, DG, Hill, D, Hill, K, Hilsabeck, T, Hinkel, DE, Ho, DD, Ho, VK, Hoffer, JK, Hoffman, NM, Hohenberger, M, Hohensee, M, Hoke, W, Holdener, D, Holdener, F, Holder, JP, Holko, B, Holunga, D, Holzrichter, JF, Honig, J, Hoover, D, Hopkins, D, Berzak Hopkins, L, Hoppe, M, Hoppe, ML, Horner, J, Hornung, R, Horsfield, CJ, Horvath, J, Hotaling, D, House, R, Howell, L, Hsing, WW, Hu, SX, Huang, H, Huckins, J, Hui, H, Humbird, KD, Hund, J, Hunt, J, Hurricane, OA, Hutton, M, Huynh, KH-K, Inandan, L, Iglesias, C, Igumenshchev, IV, Izumi, N, Jackson, M, Jackson, J, Jacobs, SD, James, G, Jancaitis, K, Jarboe, J, Jarrott, LC, Jasion, D, Jaquez, J, Jeet, J, Jenei, AE, Jensen, J, Jimenez, J, Jimenez, R, Jobe, D, Johal, Z, Johns, HM, Johnson, D, Johnson, MA, Gatu Johnson, M, Johnson, RJ, Johnson, S, Johnson, SA, Johnson, T, Jones, K, Jones, O, Jones, M, Jorge, R, Jorgenson, HJ, Julian, M, Jun, BI, Jungquist, R, Kaae, J, Kabadi, N, Kaczala, D, Kalantar, D, Kangas, K, Karasiev, VV, Karasik, M, Karpenko, V, Kasarky, A, Kasper, K, Kauffman, R, Kaufman, MI, Keane, C, Keaty, L, Kegelmeyer, L, Keiter, PA, Kellett, PA, Kellogg, J, Kelly, JH, Kemic, S, Kemp, AJ, Kemp, GE, Kerbel, GD, Kershaw, D, Kerr, SM, Kessler, TJ, Key, MH, Khan, SF, Khater, H, Kiikka, C, Kilkenny, J, Kim, Y, Kim, Y-J, Kimko, J, Kimmel, M, Kindel, JM, King, J, Kirkwood, RK, Klaus, L, Klem, D, Kline, JL, Klingmann, J, Kluth, G, Knapp, P, Knauer, J, Knipping, J, Knudson, M, Kobs, D, Koch, J, Kohut, T, Kong, C, Koning, JM, Koning, P, Konior, S, Kornblum, H, Kot, LB, Kozioziemski, B, Kozlowski, M, Kozlowski, PM, Krammen, J, Krasheninnikova, NS, Kraus, B, Krauser, W, Kress, JD, Kritcher, AL, Krieger, E, Kroll, JJ, Kruer, WL, Kruse, MKG, Kucheyev, S, Kumbera, M, Kumpan, S, Kunimune, J, Kustowski, B, Kwan, TJT, Kyrala, GA, Laffite, S, Lafon, M, LaFortune, K, Lahmann, B, Lairson, B, Landen, OL, Langenbrunner, J, Lagin, L, Land, T, Lane, M, Laney, D, Langdon, AB, Langer, SH, Langro, A, Lanier, NE, Lanier, TE, Larson, D, Lasinski, BF, Lassle, D, LaTray, D, Lau, G, Lau, N, Laumann, C, Laurence, A, Laurence, TA, Lawson, J, Le, HP, Leach, RR, Leal, L, Leatherland, A, LeChien, K, Lechleiter, B, Lee, A, Lee, M, Lee, T, Leeper, RJ, Lefebvre, E, Leidinger, J-P, LeMire, B, Lemke, RW, Lemos, NC, Le Pape, S, Lerche, R, Lerner, S, Letts, S, Levedahl, K, Lewis, T, Li, CK, Li, H, Li, J, Liao, W, Liao, ZM, Liedahl, D, Liebman, J, Lindford, G, Lindman, EL, Lindl, JD, Loey, H, London, RA, Long, F, Loomis, EN, Lopez, FE, Lopez, H, Losbanos, E, Loucks, S, Lowe-Webb, R, Lundgren, E, Ludwigsen, AP, Luo, R, Lusk, J, Lyons, R, Ma, T, Macallop, Y, MacDonald, MJ, MacGowan, BJ, Mack, JM, Mackinnon, AJ, MacLaren, SA, MacPhee, AG, Magelssen, GR, Magoon, J, Malone, RM, Malsbury, T, Managan, R, Mancini, R, Manes, K, Maney, D, Manha, D, Mannion, OM, Manuel, AM, Mapoles, E, Mara, G, Marcotte, T, Marin, E, Marinak, MM, Mariscal, C, Mariscal, DA, Mariscal, EF, Marley, EV, Marozas, JA, Marquez, R, Marshall, CD, Marshall, FJ, Marshall, M, Marshall, S, Marticorena, J, Martinez, D, Maslennikov, I, Mason, D, Mason, RJ, Masse, L, Massey, W, Masson-Laborde, P-E, Masters, ND, Mathisen, D, Mathison, E, Matone, J, Matthews, MJ, Mattoon, C, Mattsson, TR, Matzen, K, Mauche, CW, Mauldin, M, McAbee, T, McBurney, M, Mccarville, T, McCrory, RL, McEvoy, AM, McGuffey, C, Mcinnis, M, McKenty, P, McKinley, MS, McLeod, JB, McPherson, A, Mcquillan, B, Meamber, M, Meaney, KD, Meezan, NB, Meissner, R, Mehlhorn, TA, Mehta, NC, Menapace, J, Merrill, FE, Merritt, BT, Merritt, EC, Meyerhofer, DD, Mezyk, S, Mich, RJ, Michel, PA, Milam, D, Miller, C, Miller, D, Miller, DS, Miller, E, Miller, EK, Miller, J, Miller, M, Miller, PE, Miller, T, Miller, W, Miller-Kamm, V, Millot, M, Milovich, JL, Minner, P, Miquel, J-L, Mitchell, S, Molvig, K, Montesanti, RC, Montgomery, DS, Monticelli, M, Montoya, A, Moody, JD, Moore, AS, Moore, E, Moran, M, Moreno, JC, Moreno, K, Morgan, BE, Morrow, T, Morton, JW, Moses, E, Moy, K, Muir, R, Murillo, MS, Murray, JE, Murray, JR, Munro, DH, Murphy, TJ, Munteanu, FM, Nafziger, J, Nagayama, T, Nagel, SR, Nast, R, Negres, RA, Nelson, A, Nelson, D, Nelson, J, Nelson, S, Nemethy, S, Neumayer, P, Newman, K, Newton, M, Nguyen, H, Di Nicola, J-MG, Di Nicola, P, Niemann, C, Nikroo, A, Nilson, PM, Nobile, A, Noorai, V, Nora, R, Norton, M, Nostrand, M, Note, V, Novell, S, Nowak, PF, Nunez, A, Nyholm, RA, O'Brien, M, Oceguera, A, Oertel, JA, Okui, J, Olejniczak, B, Oliveira, J, Olsen, P, Olson, B, Olson, K, Olson, RE, Opachich, YP, Orsi, N, Orth, CD, Owen, M, Padalino, S, Padilla, E, Paguio, R, Paguio, S, Paisner, J, Pajoom, S, Pak, A, Palaniyappan, S, Palma, K, Pannell, T, Papp, F, Paras, D, Parham, T, Park, H-S, Pasternak, A, Patankar, S, Patel, MV, Patel, PK, Patterson, R, Patterson, S, Paul, B, Paul, M, Pauli, E, Pearce, OT, Pearcy, J, Pedrotti, B, Peer, A, Pelz, LJ, Penetrante, B, Penner, J, Perez, A, Perkins, LJ, Pernice, E, Perry, TS, Person, S, Petersen, D, Petersen, T, Peterson, DL, Peterson, EB, Peterson, JE, Peterson, JL, Peterson, K, Peterson, RR, Petrasso, RD, Philippe, F, Phipps, TJ, Piceno, E, Ping, Y, Pickworth, L, Pino, J, Plummer, R, Pollack, GD, Pollaine, SM, Pollock, BB, Ponce, D, Ponce, J, Pontelandolfo, J, Porter, JL, Post, J, Poujade, O, Powell, C, Powell, H, Power, G, Pozulp, M, Prantil, M, Prasad, M, Pratuch, S, Price, S, Primdahl, K, Prisbrey, S, Procassini, R, Pruyne, A, Pudliner, B, Qiu, SR, Quan, K, Quinn, M, Quintenz, J, Radha, PB, Rainer, F, Ralph, JE, Raman, KS, Raman, R, Rambo, P, Rana, S, Randewich, A, Rardin, D, Ratledge, M, Ravelo, N, Ravizza, F, Rayce, M, Raymond, A, Raymond, B, Reed, B, Reed, C, Regan, S, Reichelt, B, Reis, V, Reisdorf, S, Rekow, V, Remington, BA, Rendon, A, Requieron, W, Rever, M, Reynolds, H, Reynolds, J, Rhodes, J, Rhodes, M, Richardson, MC, Rice, B, Rice, NG, Rieben, R, Rigatti, A, Riggs, S, Rinderknecht, HG, Ring, K, Riordan, B, Riquier, R, Rivers, C, Roberts, D, Roberts, V, Robertson, G, Robey, HF, Robles, J, Rocha, P, Rochau, G, Rodriguez, J, Rodriguez, S, Rosen, M, Rosenberg, M, Ross, G, Ross, JS, Ross, P, Rouse, J, Rovang, D, Rubenchik, AM, Rubery, MS, Ruiz, CL, Rushford, M, Russ, B, Rygg, JR, Ryujin, BS, Sacks, RA, Sacks, RF, Saito, K, Salmon, T, Salmonson, JD, Sanchez, J, Samuelson, S, Sanchez, M, Sangster, C, Saroyan, A, Sater, J, Satsangi, A, Sauers, S, Saunders, R, Sauppe, JP, Sawicki, R, Sayre, D, Scanlan, M, Schaffers, K, Schappert, GT, Schiaffino, S, Schlossberg, DJ, Schmidt, DW, Schmitt, MJ, Schneider, DHG, Schneider, MB, Schneider, R, Schoff, M, Schollmeier, M, Schölmerich, M, Schroeder, CR, Schrauth, SE, Scott, HA, Scott, I, Scott, JM, Scott, RHH, Scullard, CR, Sedillo, T, Seguin, FH, Seka, W, Senecal, J, Sepke, SM, Seppala, L, Sequoia, K, Severyn, J, Sevier, JM, Sewell, N, Seznec, S, Shah, RC, Shamlian, J, Shaughnessy, D, Shaw, M, Shaw, R, Shearer, C, Shelton, R, Shen, N, Sherlock, MW, Shestakov, AI, Shi, EL, Shin, SJ, Shingleton, N, Shmayda, W, Shor, M, Shoup, M, Shuldberg, C, Siegel, L, Silva, FJ, Simakov, AN, Sims, BT, Sinars, D, Singh, P, Sio, H, Skulina, K, Skupsky, S, Slutz, S, Sluyter, M, Smalyuk, VA, Smauley, D, Smeltser, RM, Smith, C, Smith, I, Smith, J, Smith, L, Smith, R, Sohn, R, Sommer, S, Sorce, C, Sorem, M, Soures, JM, Spaeth, ML, Spears, BK, Speas, S, Speck, D, Speck, R, Spears, J, Spinka, T, Springer, PT, Stadermann, M, Stahl, B, Stahoviak, J, Stanton, LG, Steele, R, Steele, W, Steinman, D, Stemke, R, Stephens, R, Sterbenz, S, Sterne, P, Stevens, D, Stevers, J, Still, CB, Stoeckl, C, Stoeffl, W, Stolken, JS, Stolz, C, Storm, E, Stone, G, Stoupin, S, Stout, E, Stowers, I, Strauser, R, Streckart, H, Streit, J, Strozzi, DJ, Suratwala, T, Sutcliffe, G, Suter, LJ, Sutton, SB, Svidzinski, V, Swadling, G, Sweet, W, Szoke, A, Tabak, M, Takagi, M, Tambazidis, A, Tang, V, Taranowski, M, Taylor, LA, Telford, S, Theobald, W, Thi, M, Thomas, A, Thomas, CA, Thomas, I, Thomas, R, Thompson, IJ, Thongstisubskul, A, Thorsness, CB, Tietbohl, G, Tipton, RE, Tobin, M, Tomlin, N, Tommasini, R, Toreja, AJ, Torres, J, Town, RPJ, Townsend, S, Trenholme, J, Trivelpiece, A, Trosseille, C, Truax, H, Trummer, D, Trummer, S, Truong, T, Tubbs, D, Tubman, ER, Tunnell, T, Turnbull, D, Turner, RE, Ulitsky, M, Upadhye, R, Vaher, JL, VanArsdall, P, VanBlarcom, D, Vandenboomgaerde, M, VanQuinlan, R, Van Wonterghem, BM, Varnum, WS, Velikovich, AL, Vella, A, Verdon, CP, Vermillion, B, Vernon, S, Vesey, R, Vickers, J, Vignes, RM, Visosky, M, Vocke, J, Volegov, PL, Vonhof, S, Von Rotz, R, Vu, HX, Vu, M, Wall, D, Wall, J, Wallace, R, Wallin, B, Walmer, D, Walsh, CA, Walters, CF, Waltz, C, Wan, A, Wang, A, Wang, Y, Wark, JS, Warner, BE, Watson, J, Watt, RG, Watts, P, Weaver, J, Weaver, RP, Weaver, S, Weber, CR, Weber, P, Weber, SV, Wegner, P, Welday, B, Welser-Sherrill, L, Weiss, K, Widmann, K, Wheeler, GF, Whistler, W, White, RK, Whitley, HD, Whitman, P, Wickett, ME, Widmayer, C, Wiedwald, J, Wilcox, R, Wilcox, S, Wild, C, Wilde, BH, Wilde, CH, Wilhelmsen, K, Wilke, MD, Wilkens, H, Wilkins, P, Wilks, SC, Williams, EA, Williams, GJ, Williams, W, Williams, WH, Wilson, DC, Wilson, B, Wilson, E, Wilson, R, Winters, S, Wisoff, J, Wittman, M, Wolfe, J, Wong, A, Wong, KW, Wong, L, Wong, N, Wood, R, Woodhouse, D, Woodruff, J, Woods, DT, Woods, S, Woodworth, BN, Wooten, E, Wootton, A, Work, K, Workman, JB, Wright, J, Wu, M, Wuest, C, Wysocki, FJ, Xu, H, Yamaguchi, M, Yang, B, Yang, ST, Yatabe, J, Yeamans, CB, Yee, BC, Yi, SA, Yin, L, Young, B, Young, CS, Young, CV, Young, P, Youngblood, K, Zacharias, R, Zagaris, G, Zaitseva, N, Zaka, F, Ze, F, Zeiger, B, Zika, M, Zimmerman, GB, Zobrist, T, Zuegel, JD, Zylstra, AB, Indirect Drive ICF Collaboration, Collaboration, Indirect Drive ICF, AWE Plc, Lawrence Livermore National Laboratory, and U.S Department of Energy

Subjects
General Physics, 02 Physical Sciences, General Physics and Astronomy, Indirect Drive ICF Collaboration, 01 Mathematical Sciences, 09 Engineering
Abstract

For more than half a century, researchers around the world have been engaged in attempts to achieve fusion ignition as a proof of principle of various fusion concepts. Following the Lawson criterion, an ignited plasma is one where the fusion heating power is high enough to overcome all the physical processes that cool the fusion plasma, creating a positive thermodynamic feedback loop with rapidly increasing temperature. In inertially confined fusion, ignition is a state where the fusion plasma can begin "burn propagation" into surrounding cold fuel, enabling the possibility of high energy gain. While "scientific breakeven" (i.e., unity target gain) has not yet been achieved (here target gain is 0.72, 1.37 MJ of fusion for 1.92 MJ of laser energy), this Letter reports the first controlled fusion experiment, using laser indirect drive, on the National Ignition Facility to produce capsule gain (here 5.8) and reach ignition by nine different formulations of the Lawson criterion.

Published
2022

26. A standardized system and App for continuous patient symptom logging in gastroduodenal disorders: design, implementation, and validation

Author

Sebaratnam, G, primary, Karulkar, N, additional, Calder, S, additional, Woodhead, JST, additional, Keane, C, additional, Carson, D, additional, Varghese, C, additional, Du, P, additional, Waite, S, additional, Tack, J, additional, Andrews, CN, additional, Broadbent, E, additional, Gharibans, A, additional, and O’Grady, G, additional

Published
2021
Full Text
View/download PDF

27. An open‐label phase 1/2 study of favezelimab plus pembrolizumab in patients with relapsed/refractory classical Hodgkin lymphoma with/without previous anti‐PD‐1 treatment.

Author

Lavie, D., Johnson, N., Borchmann, P., Herrera, A. F., Avigdor, A., Gasiorowski, R., Gregory, G., Keane, C., Vucinic, V., Bazargan, M., Herishanu, Y., Minuk, L., Tzoran, I., Andreadis, C., Armand, P., Kuruvilla, J., Zinzani, P. L., West, R. Marceau, Pillai, P., and Marinello, P.

Subjects
HODGKIN'S disease, PEMBROLIZUMAB
Abstract

B Introduction: b Dual blockade of PD-1 and lymphocyte-activation gene (LAG-3) has shown antitumor activity; however, the activity of the combination for patients (pts) with relapsed or refractory (R/R) classical Hodgkin's lymphoma (cHL) is unclear. An open-label phase 1/2 study of favezelimab plus pembrolizumab in patients with relapsed/refractory classical Hodgkin lymphoma with/without previous anti-PD-1 treatment Pts in cohort 1 had no prior anti-PD-1 therapy; pts in cohort 2 had progression within 12 weeks after >=2 doses of anti-PD-1 therapy, per Cheson 2007 criteria. [Extracted from the article]

Published
2023
Full Text
View/download PDF

28. IMMUNE PRIMING WITH NIVOLUMAB FOLLOWED BY NIVOLUMAB & RITUXIMAB IN 1 ST LINE TREATMENT OF FOLLICULAR LYMPHOMA: THE PHASE 2 1 ST FLOR STUDY

Author

Hawkes, E. A., primary, Lee, S. T., additional, Chong, G., additional, Gilbertson, M., additional, Grigg, A., additional, Churilov, L., additional, Fancourt, T., additional, Keane, C., additional, Ritchie, D., additional, Koldej, R., additional, Agarwal, R., additional, Manos, K., additional, Smith, C., additional, Houdyk, K., additional, Hawking, J., additional, and Barraclough, A., additional

Published
2021
Full Text
View/download PDF

29. INTRATUMORAL T‐CELLS HAVE A DIFFERENTIAL IMPACT ON FDG‐PET PARAMETERS IN FOLLICULAR LYMPHOMA

Author

Nath, K., primary, Law, Soi‐C., additional, Talaulikar, D., additional, Sabdia, M. B., additional, Gunawardana, J., additional, Long, L. M., additional, Shanavas, M., additional, Tsang, H., additional, Tobin, J. W., additional, Halliday, S.‐J., additional, Hernandez, A., additional, Cross, D., additional, Bird, R., additional, Jain, S., additional, Keane, C., additional, Trotman, J., additional, Law, P., additional, and Gandhi, M. K., additional

Published
2021
Full Text
View/download PDF

30. Phase i Dose Escalation Study of Radiotherapy and Durvalumab (MEDI4736) in Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL): The RaDD Study.

Author

Manos K., Khor R., Chong G., Palmer J., MacManus M., Keane C., Scott A.M., Shortt J., Ritchie D., Churilov L., Johnston L., Witkowski T., Barraclough A., Lee S.T., Lin W., Koldej R., Hawkes E., Manos K., Khor R., Chong G., Palmer J., MacManus M., Keane C., Scott A.M., Shortt J., Ritchie D., Churilov L., Johnston L., Witkowski T., Barraclough A., Lee S.T., Lin W., Koldej R., and Hawkes E.

Abstract

Background: Most DLBCL & FL responds well to first line treatment, yet relapsed disease outcomes are poor. Immune checkpoint inhibition (ICI) with PD/PD1 inhibitors (PD1i) yield high response rates in some lymphomas; though single agent PD1i yields a disappointing ORR of 10% in heavily pre-treated DLBCL, some responses are durable. RT stimulates anti-tumour immunity through several mechanisms and may enhance response to ICI. Concurrent ICI & RT is synergistic in preclinical studies & solid tumours, improving local & distant (abscopal) response. RT to multiple disease sites may broaden the spectrum of tumour antigen release and overcome clonal variation between disease sites to further augment the immune response. A dose-response relationship between RT and antigen release has yet to be established. This phase I dose escalation study aims to determine the safety profile of RT in combination with durvalumab, an anti-PD-L1 monoclonal antibody, in relapsed/refractory DLBCL and FL. Study Design and Methods: RaDD (NCT03610061) is a phase I dose escalation study to determine the safety profile of escalating dose and number of sites of RT in combination with durvalumab in relapsed/refractory (RR) DLBCL & FL. Eligible patients (pts) have received >= 1 prior line of therapy and are ineligible for or relapsed after autologous stem cell transplant (auto-SCT). Pts with active autoimmune disease, CNS involvement, prior allogeneic-SCT or chronic steroid use are excluded. RT dose and site escalation proceeds according to a 3+3 design with 6 dose levels (cohorts 1-6). Treatment comprises external beam RT to target site(s) daily for 5 days (Cohorts 1-5); Cohort 6 receives a further 5 daily fractions (max 30Gy). Durvalumab 1500mg IV commences day 2 of RT and continues 4-weekly until disease progression. Pts can continue until a second radiological progression if clinical benefit is ongoing. The dose limiting toxicity period is 28 days from start of RT. The primary endpoint is the toxi

Published
2021

31. Phase I study of radiotherapy (RT) & durvalumab in relapsed/refractory diffuse large B-cell lymphoma (DLBCL) & follicular lymphoma (FL): The RADD study.

Author

Hawkes E.A., Manos K., Chong G., Palmer J., MacManus M.P., Keane C., Scott A.M., Shortt J., Ritchie D., Churilov L., Johnston L., Witkowski T., Barraclough A.A., Lee S.T., Lin W., Koldej R., Khor R., Hawkes E.A., Manos K., Chong G., Palmer J., MacManus M.P., Keane C., Scott A.M., Shortt J., Ritchie D., Churilov L., Johnston L., Witkowski T., Barraclough A.A., Lee S.T., Lin W., Koldej R., and Khor R.

Abstract

Background: Most DLBCL & FL responds well to first line treatment, yet relapsed disease outcomes are poor. PD1/PDL1 inhibitors yield high response rates in some lymphomas, but single agent therapy in heavily pre-treated pts are disappointing. RT stimulates anti-tumor immunity through several mechanisms and may enhance response to immune checkpoint inhibition (ICI). Concurrent ICI & RT is synergistic in preclinical studies & solid tumors, improving local & distant (abscopal) response. RT to multiple disease sites may broaden the spectrum of tumor antigen release and overcome clonal variation between disease sites to further augment the immune response. Method(s): RaDD (NCT03610061) is a phase I, 3+3 dose escalation study to determine the safety profile of escalating dose & number of sites of RT in combination with Durvalumab (anti-PD-L1 antibody) in RR DLBCL & FL. Eligible pts (i.e. >=1 prior therapy, ineligible for auto-SCT, no contraindication to PDL1i) receive 5 fractions of external beam RT to target site(s). 5 RT dose & site levels are included (dose range 2.5Gy-20Gy to 1-3 sites). Durvalumab 1500mg IV commences day 2 of RT and continues 4-weekly until confirmed disease progression. The DLT period is 28 days from start of RT. Primary endpoint is the recommended phase two dose (RP2D) of RT in combination with durvalumab. Secondary endpoints include response rates, PFS & OS. Correlative studies will examine the tumour-immune system interaction; an exploratory PET substudy with novel tracers for durvalumab (89Zr-Durvalumab) & CD8+ T cells (89Zr -Df-IAB22M2C) will also be performed. Projected enrollment for determination of maximum tolerated dose (MTD) & RP2D is 6-30 pts pending toxicity. Recruitment will continue to 36 pts for secondary endpoint analysis. 9 pts are enrolled across cohorts 1-3 to date.

Published
2021

32. Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression

Author

Proctor, M, Cruz, JLG, Daignault-Mill, SM, Veitch, M, Zeng, B, Ehmann, A, Sabdia, M, Snell, C, Keane, C, Dolcetti, R, Haass, NK, Wells, JW, Gabrielli, B, Proctor, M, Cruz, JLG, Daignault-Mill, SM, Veitch, M, Zeng, B, Ehmann, A, Sabdia, M, Snell, C, Keane, C, Dolcetti, R, Haass, NK, Wells, JW, and Gabrielli, B

Abstract

Drugs selectively targeting replication stress have demonstrated significant preclinical activity, but this has not yet translated into an effective clinical treatment. Here we report that targeting increased replication stress with a combination of Checkpoint kinase 1 inhibitor (CHK1i) with a subclinical dose of hydroxyurea targets also promotes pro-inflammatory cytokine/chemokine expression that is independent of cGAS-STING pathway activation and immunogenic cell death in human and murine melanoma cells. In vivo, this drug combination induces tumour regression which is dependent on an adaptive immune response. It increases cytotoxic CD8+ T cell activity, but the major adaptive immune response is a pronounced NKT cell tumour infiltration. Treatment also promotes an immunosuppressive tumour microenvironment through CD4+ Treg and FoxP3+ NKT cells. The number of these accumulated during treatment, the increase in FoxP3+ NKT cells numbers correlates with the decrease in activated NKT cells, suggesting they are a consequence of the conversion of effector to suppressive NKT cells. Whereas tumour infiltrating CD8+ T cell PD-1 and tumour PD-L1 expression was increased with treatment, peripheral CD4+ and CD8+ T cells retained strong anti-tumour activity. Despite increased CD8+ T cell PD-1, combination with anti-PD-1 did not improve response, indicating that immunosuppression from Tregs and FoxP3+ NKT cells are major contributors to the immunosuppressive tumour microenvironment. This demonstrates that therapies targeting replication stress can be well tolerated, not adversely affect immune responses, and trigger an effective anti-tumour immune response.

Published
2021

34. Astrophysically relevant radiation hydrodynamics experiment at the National Ignition Facility

Author

Kuranz, C. C., Park, H.-S., Remington, B. A., Drake, R. P., Miles, A. R., Robey, H. F., Kilkenny, J. D., Keane, C. J., Kalantar, D. H., Huntington, C. M., Krauland, C. M., Harding, E. C., Grosskopf, M. J., Marion, D. C., Doss, F. W., Myra, E., Maddox, B., Young, B., Kline, J. L., Kyrala, G., Plewa, T., Wheeler, J. C., Arnett, W. D., Wallace, R. J., Giraldez, E., and Nikroo, A.

Published
2011
Full Text
View/download PDF

36. National scientific medical meeting 1995 abstracts: Oral presentations

Author

Norris, S., Collins, C., Hegarty, J., O’Farrelly, C., Carton, J., Madrigal, L., O’Donoghue, D. P., O’Farrelly, C., Holloway, H., Fielding, J. F., Mullins, W., Hone, S. W., Donnelly, M., Powell, F., Blayney, A. W., Cahill, E. A., Daly, S. F., Turner, M. J., Sullivan, P. A., McLoughlin, M., Skelly, M. M., Mulcahy, H. E., Connell, T., O’Donoghue, D. P., Duggan, C., Duffy, M. J., Troy, A., Sheahan, K., Whelan, A., Herra, C. M., Keane, C. T., Johnson, H., Lee, B., Doherty, E., McDonnell, T., Mulherin, D., FitzGerald, O., Bresnihan, B., Hassett, H. M., Boyce, A., Greig, V., O’Herlihy, C., Smyth, P. P. A., Roche, E. F., McCormack, I., Tempany, E., Cullen, M. J., Smith, D. F., Smyth, P. P. A., McBrinn, Y., Murray, B., Freaney, R., Keating, D., McKenna, M. J., O’Hare, J. A., Alam, H., Raza, Q., Geoghegan, M., Killalea, S., Hall, M., Feely, J., Kyne, L., O’Hara, B., Cullen, M., Rea, I. M., Donnelly, J. P., Stout, R. W., Lacey, P., Donnelly, M. J., McGrath, J., Hennessy, T. P., Timon, C. V. I., Hyde, D., Xia, H. X., Keane, C. T., Buckley, M., O’Morain, C., Buckley, M., Keating, S., Xia, H., Hyde, D., O’Morain, C., McGrath, J. P., Stuart, R. C., Lawlor, P., Byrne, P. J., Walsh, T. N., Hennessy, T. P. J., Skelly, M. M., Mulcahy, H. E., Connell, T., O’Donoghue, D. P., Duggan, C., Duffy, M., Troy, A., Sheahan, K., Norris, S., Tubridy, M., Redmond, J., Hegarty, J., Holloway, H., Fielding, J. F., Mullins, W., Monahan, K., Murphy, R. P., Headon, D. R., O’Gorman, T., O’Reilly, F. M., Darby, C., Fielding, J. F., Murphy, G. M., Murphy, A., Codd, M., Powell, F., Dervan, P., Lawlor, D., Loughlin, S. O., Flanagan, N., Watson, R., Barnes, L., Flanagan, N., Watson, R., Kilgallen, C., Sweeney, E., Mynes, A., Mooney, D., Donoghue, I., Browne, O., Kirrane, J. A., Murphy, G. M., McKenna, D., Young, M., McKenna, D., Young, M., O’Toole, E., Young, M., O’Briain, S., Srinivasan, U., Feighery, C., Leonard, N., Jones, E., O’Farrelly, C., Moloney, M. A., O’Farrelly, C., Weir, D. G., Lawler, M., O’Neill, A., Gowing, H., Pamphilon, D., McCann, S. R., O’Toole, G., Orren, A., Seifer, C. M., Crowley, D. C., Sheehan, G. J., Deignan, T., Kelly, J., O’Farrelly, C., Tormey, V. J., Faul, J., Leonard, C., Burke, C. M., Poulter, L. W., Collins, C., Lynch, S., Madrigal, L., Norris, S., McEntee, G., Traynor, O., Hegarty, J., O’Farrelly, C., Barry, E., Collins, C., Costello, P., Keavney, A., O’Donoghue, D. P., O’Farrelly, C., Willoughby, R., Feighery, C., O’Donnell, C., Cahill, M., Earley, A., Eustace, P., Osborne, R., Cahill, M., Saidlear, C., Holmes, B., Early, A., Eustace, P., Moran, A. P., Neisser, A., Polt, R. J., Bernheimer, H., Kainz, M., Schwerer, B., Gallagher, L., Cahill, M., Saidlear, C., Early, A., Firth, R., Eustace, P., Kennedy, N., McGilloway, E., Redmond, J., McGilloway, E., Kennedy, N., Tubridy, N., Shields, K., Cullen, W. K., Rowan, M. J., Moore, A. R., Rowan, M., Feely, J., Coakley, D., Lawlor, B., Swanwick, G., Al-Naeemi, R., Redmond, J., Murphy, R., Feely, J., Codd, N. M., Goggins, M., Kennedy, N. P., Mallon, B. L., Kennedy, N. P., Mulherin, D., FitzGerald, O., Bresnihan, B., Mulcahy, H., Skelly, M., Donoghue, D. O., McCarthy, D., Saunders, A., Mulherin, D., Bresnihan, B., FitzGerald, O., Veale, D. J., Belch, J. J. F., Mulherin, D., Bresnihan, B., FitzGerald, O., Veale, D. J., Belch, J. J. F., Mulherin, D., FitzGerald, O., Bresnihan, B., Costello, P., Breathnach, D., Murphy, E., Mulherin, D., FitzGerald, O., Bresnihan, B., Breathnach, D., Costello, P., Mulherin, D., Bresnihan, B., FitzGerald, O., Breathnach, D., Mulherin, D., Costello, P., Bresnihan, B., FitzGerald, O., Kernohan, G., Gibson, K., Wilson, A. G., Duff, G. W., de Vries, N., van de Putte, L. B. A., Donoghue, J., O’Kelly, F., Johnson, Z., Maher, T., Kyne, L., Moran, A., Keane, C., O’Neill, D., Horgan, N., Barragry, J. M., O’Neill, D., O’Herlihy, C., Campbell, D. M., Behan, M., O’Connell, P. R., Donnelly, V. S., Crowley, D., Geary, M., Boylan, P., Geary, M., Fanagan, M., Boylan, P., Hickey, K., Teoh, T., Doyle, M., Harrison, R., Hickey, K., Lyons, D., Shenouda, Y., Coughlan, M., McKenna, P., Hickey, K., Shenouda, Y., Lyons, D., McKenna, P., Coughlan, M., Lenehan, P., Foley, M., Kelehan, P., Ravichandran, P., Kelly, M., Conroy, A., Fitzpatrick, C., Egan, D., Regan, C. L., McAdam, B. V., McParland, P., Boylan, P., FitzGerald, G. A., Fitzgerald, D. J., Sharma, S. C., Foran, K., Barry-Kinsella, C., Harrison, R. F., Gillespie, F. J., O’Mahony, P., Boyle, M., White, M. J., Donohoe, F., Birrane, Y., Naughton, M., Tempany, E., Fitzsimons, R. B., Piracha, M., McConkey, S., Griffin, E., Hayes, E., Clarke, T., Parfrey, N., Butler, K., Fitzpatrick, C., Malone, A. J., Kearney, P. J., Duggan, P. F., Lane, A., Keville, R., Turner, M., Barry, S., Sloan, D., Gallagher, S., Darby, M., Galligan, P., Stack, J., Walsh, N., O’Sullivan, M., Fitzgerald, M., O’Sullivan, M., Meagher, D., Sloan, D., Browne, S., Meagher, D., Larkin, C., Lane, A., Casey, P., O’Callaghan, E., Walsh, N., Rooney, S., Walsh, E., Morris, M., Lane, A., Burke, T., Larkin, C., O’Callaghan, E., Browne, S., Roe, M., Lane, A., Larkin, C., O’Callaghan, E., Maher, C., Wrigley, M., Gill, M., Burgess, M., Corcoran, E., Walsh, D., Gilmer, B., Johnson, H., Hayes, C. B., Thornton, L., Fogarty, J., Lyons, R., O’Connor, M., Delaney, V., Buckley, K., Johnson, Z., Johnson, Z., Lillis, D., Delany, V., Hayes, C., Dack, P., Igoe, D., Gilmer, B., O’Neill, H. J., Johnson, H., Igoe, D., Delaney, V., Johnson, Z., Kelly, P., McKeown, D., Clancy, L., Varghese, G., Hennessy, S., Codd, M., Gilmartin, J. J., Birthistle, K., Carrington, D., Maguire, H., Atkinson, P., Foley-Nolan, C., Lynch, M., Cryan, B., Whyte, D., Cryan, B., Conlon, C., Foley-Nolan, C., Johnson, Z., Hayes, C., Delany, V., Kucinskas, V., Usinskiene, U., Sakalyte, I., Johnson, Z., Hayes, C., Delaney, V., Dack, P., Gill, M., Dawson, E., Molloy, K., Goulden, N., Lawler, M., McCann, S. R., Doyle, J., Lawlor, E., Lawler, M., Harrington, M. G., El-Nageh, N., Nolan, M. -L., El-Nageh, N., Nolan, M. -L., Harrington, M. G., Lawlor, E., O’Riordan, J., McCann, S. R., Judge, G., Crotty, G., Finch, T., Borton, M., Barnes, T., Gilligan, O., Lee, G., Limmer, R., Madden, M., Whyte, D., Cryan, B., Bergin, C., O’Leary, A., Keating, S., Mulcahy, F., Wallis, F., Glennon, M., Cormican, M., NiRiain, U., Heiginbothom, M., Gannon, F., Smith, T., O’Sullivan, C., Hone, R., Orren, A., Caugant, D. A., Fijen, C. A. P., Van Schalkwyk, E. J., Coetzee, G. J., Lynch, M., Cryan, B., Riain, U. Ni, Cormican, M. G., Park, L., Flynn, J., Glennon, M., O’Connor, M., Regazzoli, V., O’Connor, M., Hayes, M., Nicholson, G., Higgins, P., NiRiain, U., Flynn, N., Corbett-Feeney, G., Conway, D. J., Sheahan, K., O’Higgins, N. J., Smyth, P. P. A., Rajendiran, S., Byrne, J., Kilfeather, E., Dingle, P., Hunter, M., Kelehan, P., Al-Ghazal, S. K., Stanley, P., Palmer, J., Hong, A., Al-Ghazal, S. K., Saxby, P., Al-Ghazal, S. K., Saxby, P., McConkey, S., Sheehan, D., Regan, I., O’Mullane, J., Chaoimh, M. Ni, Leahy, M., Heffron, J. J., Lehane, M., Keohane, C., O’Leary, N., Sheehan, M., Renny-Walsh, E., Whelton, M. J., Doyle, C. T., Webster, J., Benjamin, N., Lyons, D., FitzGerald, S., Chadha, J. S., FitzGerald, M. G., FitzGerald, G. R., Hemeryck, L., McGettigan, P., Feely, J., McGettigan, P., Feely, J., McGettigan, P., Golden, J., Feely, J., Arthur, N., Wen, S. Y., Killalea, S., Deegan, P., McGettigan, P., Feely, J., Cooke, T., Adebayo, G. I., Feely, J., Gaffney, P., Sinnot, M., O’Riordan, D., Hayes, T., O’Connor, C. M., FitzGerald, M. X., Costello, C., Finlay, G., Hayes, J., O’Connor, C., FitzGerald, M. X., McMahon, K., O’Farrelly, C., O’Connor, C., FitzGerald, M. X., Donnelly, M. J., Hone, S., Robertson, J., Coakley, R., O’Neill, S., Walsh, M., McCarthy, J., Lannon, D., Wood, A. E., Sharkey, R., Mulloy, E., Long, M., Kilgallen, I., O’Neill, S., Faul, J., Tormey, V., Leonard, C., Burke, C. M., Poulter, L. W., Horne, S., Tormey, V. J., Faul, J., Leonard, C., Burke, C. M., Feeney, T., Muiré, Ó. Ó, Gilmartin, J. J., Griffin, M. J., Hughes, D., Knaggs, A., Magee, D., Donnelly, M., McCrory, C., March, B., Hone, R., Phelan, D., White, M., Fabry, J., Lynch, M., Buggy, D., Cooney, C., Hughes, D., McCrory, C., Aziz, E., O’Herlihy, C., Kelly, J., O’Keefe, D., McShane, A. J., Boylan, J., Tobin, E., Smith, T., Motherway, C., Colreavy, F., Denish, N., Dwyer, R., Bergin, A., O’Brien, K., MacSullivan, R., Carson, K. D., Blunnie, W. P., Moriarty, D. C., Carson, K. D., Blunnie, W. P., Moriarty, D. C., Kinirons, B., Lyons, B., Cregg, N., Casey, W., Moore, K. P., Colbert, S. A., Ecoffey, C., O’Gorman, D., Fitzgerald, J., Phelan, D., Diamond, P., Codd, M. B., Sugrue, D. D., Kellett, J., Tighe, M., McKenna, C. J., Galvin, J., McCann, H. A., Sugrue, D. D., McKenna, C. J., Codd, M. B., McCann, H. A., Sugrue, D. D., Scallon, A., Buckley, M., Fraser, A., Norton, M., Tomkin, G., Graham, I., Byrne, A., Maher, M., Moran, N., Fitzgerald, D., O’Callaghan, D., Coyle, D., Nugent, A. G., McGurk, C., Johnston, G. D., McGurk, C., Nugent, A., Silke, B., Nugent, A. G., Johnston, G. D., Murphy, N., Jennings, L., Pratico, D., Doyle, C., Fitzgerald, D., Hennessy, T., McCann, H., Sugrue, D., Hennessy, T., Codd, M., Donnelly, S., Hennessy, A., Hartigan, C., McCann, H., Sugrue, D., Hennessy, T., Codd, M., Donnelly, S., Hennessy, A., Hartigan, C., McCann, H., Sugrue, D., Hennessy, T., MacDonald, D., Blake, S., McCann, H., Sugrue, D., Hennessy, T., Sugrue, D., McCann, H., Hennessy, T., McCann, H., Sugrue, D., Hennessy, T., McDonald, D., Blake, S., Dominque, D., Sugrue, D., McMechan, S. R., MacKenzie, G., Allen, J., Wright, G. T., Dempsey, G. J., Crawley, M., Anderson, J., Adgey, A. A. J., Harbinson, M. T., Campbell, N. P. S., Wilson, C. M., Ellis, P. K., McIlrath, E. M., Freaney, R., McShane, A., Keaveny, T. V., McKenna, M. J., Rabenstein, K., Scheller, F., Pfeiffer, D., Urban, C., Moser, I., Jobst, G., Manz, A., Verpoorte, S., Dempsey, F., Diamond, D., Smyth, M., Rabenstein, K., Dempsey, E., McShane, A., Keaveny, T. V., McKenna, M. J., Freaney, R., Hamilton, V., Dwyer, R., Twomey, J., Crowley, R., Fenelon, L., Walsh, F., McCann, J., McDonagh, P., White, M., McGovern, E., Luke, D., Phelan, D., McCrory, C., Crowley, K., Lyons, B., Mannion, D., Wood, A. E., Casey, W., Murphy, D., Clarkson, K., Carton, E., Higgins, P., Leonard, I., O’Toole, D., Staunton, M., Phelan, D., Srinivasan, U., Leonard, N., Jones, E., Moloney, M. A., Weir, D. G., O’Farrelly, C., Feighery, C., Griffin, M., Owens, D., Collins, P., Johnson, A., Tomkin, G. H., Herity, N. A., Allen, J. D., Silke, B., Adgey, A. A. J., O’Reilly, F. M., Darby, C., O’Moore, R., Fielding, J. F., Murphy, G. M., Crotty, G. M., Judge, G., McCann, S. R., DeArce, M., Nugent, A. G., McGurk, C., Johnston, G. D., Nikookam, K., Keenan, P., Cregan, D., Firth, R., O’Meara, N., Forman, S., Cusack, D. A., and Farrell, B.

Published
1995
Full Text
View/download PDF

38. National Scientific Medical Meeting 1994 Abstracts

Author

Carson, K. D., Grimes, S. B., McGinley, J. M., Thornton, M. T., Mulhall, J., Bourke, A. M., McCrory, C., Marsh, B., Hone, R., Phelan, D., White, M., Fabry, J., Hughes, D., Carson, K., Donnelly, M., Shanahan, E., Fitzpatrick, G. J., Bourke, M., Warde, D., Buggy, D., Hughes, N., Taylor, A., Dowd, N., Markham, T., Blunnie, W., Nicholson, G., O’Leary, E., Cunningham, A. J., Dwyer, R., McMechan, S., Cullen, C., Dempsey, G., Wright, G., MacKenzie, G., Anderson, J., Adgey, J., Walsh, M., O’Callaghan, P., Graham, I., O’Hare, J. A., Geoghegan, M., Iman, N., Shah, P., Chander, R., Lavin, F., Daly, K., Johnston, P. W., Imam, Z., Adgey, A. A. J., Rusk, R. A., Richardson, S. G., Hale, A., Kinsella, B. M., FitzGerald, G. A., King, G., Crean, P., Gearty, G., Cawley, T., Docherty, J. R., Geraghty, J., Osborne, H., Upton, J., D’Arcy, G., Stinson, J., Cooke, T., Colgan, M. P., Hall, M., Tyrrell, J., Gaffney, K., Grouden, M., Moore, D. J., Shanik, G., Feely, J., Delanty, N., Reilly, M., Lawson, J. A., Fitzgerald, D. J., Reilly, M. P., McAdam, B. F., Bergin, C., Walshe, M. J., Herity, N. A., Allen, J. D., Silke, B., Singh, H. P., O’Neill, S., Hargrove, M., Coleman, E., Shorten, E., Aherne, T., Kelly, B. E., Hill, D. H., McIlrath, E., Morrow, B. C., Lavery, G. G., Blackwood, B., Fee, J. P. H., Kevin, L., Doran, M., Tansey, D., Boylan, I., McShane, A. J., O’Reilly, G., Tuohy, B., Grainger, P., Larkin, T., Mahady, J., Malone, J., Condon, C., Donoghue, T., O’Leary, J., Lyons, J. F., Tay, Y. K., Tham, S. N., Khoo Tan, H. S., Gibson, G., O’Grady, A., Leader, M., Walshe, J., Carmody, M., Donohoe, J., Murphy, G. M., O’Connor, W., Barnes, L., Watson, R., Darby, C., O’Moore, R., Mulcahy, F., O’Toole, E., O’Briain, D. S., Young, M. M., Buckley, D., Healy, E., Rogers, S., Ni Scannlain, N., McKenna, M. J., McBrinn, Y., Murray, B., Freaney, R., Barrett, E., Razza, Q., Abuaisha, F., Powell, D., Murray, T. M., Powell, A. M., O’Mongain, E., O’Neill, J., Kernan, R. P., O’Connor, P., Clarke, D., Fearon, U., Cunningham, S. K., McKenna, T. J., Hayes, F., Heffernan, A., Sheahan, K., Harper, R., Johnston, G. D., Atkinson, A. B., Sheridan, B., Bell, P. M., Heaney, A. P., Loughrey, G., McCance, D. R., Hadden, D. R., Kennedy, A. L., McNamara, P., O’Shaughnessy, C., Loughrey, H. C., Reid, I., Teahan, S., Caldwell, M., Walsh, T. N., McSweeney, J., Hennessy, T. P., Caldwell, M. T. P., Byrne, P. J., Hennessy, T. P. J., El-Magbri, A. A., Stevens, F. M., O’Sullivan, R., McCarthy, C. F., Laundon, J., Heneghan, M. A., Kearns, M., Goulding, J., Egan, E. L., McMahon, B. P., Hegarty, F., Malone, J. F., Merriman, R., MacMathuna, P., Crowe, J., Lennon, J., White, P., Clarke, E., Prabhakar, M. C., Ryan, E., Graham, D., Yeoh, P. L., Kelly, P., McKeogh, D., O’Keane, C., Kitching, A., Mulligan, E., Gorey, T. F., Mahmud, N., O’Connell, M., Goggins, M., Keeling, P. W. N., Weir, D. G., Kelleher, D., McDonald, G. S. A., Maguire, D., O’Sullivan, G., Harvey, B., Cherukuri, A., McGrath, J. P., Timon, C., Lawlor, P., O’Shea, J., Buckley, M., English, L., Walsh, T., O’Morain, C., Lavelle, S. M., Kanagaratnam, B., Harding, B., Murphy, B., Kavanagh, J., Kerr, D., Lavelle, E., O’Gorman, T., Liston, S., Fitzpatrick, C., Fitzpatrick, P., Turner, M., Murphy, A. W., Cafferty, D., Dowling, J., Bury, G., Kaf Al-Ghazal, S., Zimmermann, E., O’Donoghue, J., McCann, J., Sheehan, C., Boissel, L., Lynch, M., Cryan, B., Fanning, S., O’Meara, D., Fennell, J., Byrne, P. M., Lyons, D., Mulcahy, R., Pooransingh, A., Walsh, J. B., Coakley, D., O’Neill, D., Ryall, N., Connolly, P., Namushi, R., Lawler, M., Locasciulli, A., Bacigalupo, A., Humphries, P., McCann, S. R., Pamphilon, D., Reidy, M., Madden, M., Finch, T., Borton, M., Barnes, C. A., Lawlor, S. E., Gardiner, N., Egan, L. J., Orren, A., Doherty, J., Curran, C., O’Hanlon, D., Kent, P., Kerin, M., Maher, D., Given, H. F., Lynch, S., McManus, R., O’Farrelly, C., Madrigal, L., Feighery, C., O’Donoghue, D., Whelan, C. A., Rea, I. M., Stewart, M., Campbell, P., Alexander, H. D., Crockard, A. D., Morris, T. C. M., Maguire, H., Davidson, F., Kaminski, G. Z., Butler, K., Hillary, I. B., Parfrey, N. A., Crowley, B., McCreary, C., Keane, C., O’Reilly, M., Goh, J., Kennedy, M., Fitzgerald, M., Scott, T., Murphy, S., Hildebrand, J., Holliman, R., Smith, C., Kengasu, K., Riain, U. Ni, Cormican, M., Flynn, J., Glennon, M., Smith, T., Whyte, D., Keane, C. T., Barry, T., Noone, D., Maher, M., Dawson, M., Gilmartin, J. J., Gannon, F., Eljamel, M. S., Allcut, D., Pidgeon, C. N., Phillips, J., Rawluk, D., Young, S., Toland, J., Deveney, A. M., Waddington, J. L., O’Brien, D. P., Hickey, A., Maguire, E., Phillips, J. P., Al-Ansari, N., Cunney, R., Smyth, E., Sharif, S., Eljamel, M., Pidgeon, C., Maguire, E. A., Burke, E. T., Staunton, H., O’Riordan, J. I., Hutchinson, M., Norton, M., McGeeney, B., O’Connor, M., Redmond, J. M. T., Feely, S., Boyle, G., McAuliffe, F., Foley, M., Kelehan, P., Murphy, J., Greene, R. A., Higgins, J., Darling, M., Byrne, P., Kondaveeti, U., Gordon, A. C., Hennelly, B., Woods, T., Harrison, R. F., Geary, M., Sutherst, J. R., Turner, M. J., DeLancey, J. O. L, Donnelly, V. S., O’Connell, P. R., O’Herlihy, C., Barry-Kinsella, C., Sharma, S. C., Drury, L., Lewis, S., Stratton, J., Ni Scanaill, S., Stuart, B., Hickey, K., Coulter-Smith, S., Moloney, A., Robson, M. S., Murphy, M., Keane, D., Stronge, J., Boylan, P., Gonsalves, R., Blankson, S., McGuinness, E., Sheppard, B., Bonnar, J., MacDonagh-White, C. M., Kelleher, C. C., Newell, J., White, O., Young, Y., Hallahan, C., Carroll, K., Tipton, K., McDermott, E. W., Reynolds, J. V., Nolan, N., McCann, A., Rafferty, R., Sweeney, P., Carney, D., O’Higgins, N. J., Duffy, M. J., Grimes, H., Gallagher, S., O’Hanlon, D. M., Strattan, J., Lenehan, P., Robson, M., Cusack, Y. A., O’Riordain, D., Mercer, P. M., Smyth, P. P. A., Gallagher, H. J., Moule, B., Cooke, T. G., McArdle, C. S., Burke, C., Vance, A., Saidtéar, C., Early, A., Eustace, P., Maguire, L., Cullinane, A. B. P., Prosser, E. S., Coca-Prados, M., Harvey, B. J., Saidléar, C., Orwa, S., Fitzsimons, R. B., Bradley, O., Hogan, M., Zimmerman, L., Wang, J., Kuliszewski, M., Liu, J., Post, M., Premkumar, Conran, M. J., Nolan, G., Duff, D., Oslizlok, P., Denham, B., O’Connell, P. A, Birthistle, K., Hitchcock, R., Carrington, D., Calvert, S., Holmes, K., Smith, D. F., Hetherton, A. M., Mott, M. G., Oakhill, A., Foreman, N., Foot, A., Dixon, J., Walsh, S., Mortimer, G., O’Sullivan, C., Kilgallen, C. M., Sweeney, E. C., Brayden, D. J., Kelly, J. G., McCormack, P. M. E., Hayes, C., Johnson, Z., Dack, P., Hosseini, J., O’Connell, T., Hemeryck, L., Condren, L., McCormack, P., McAdam, B., Lawson, J., Keimowitz, R., O’Leary, A., Pilkington, R., Adebayo, G. I., Gaffney, P., McGettigan, P., McManus, J., O’Shea, B., Wen, Y., Killalea, S., Golden, J., Swanwick, G., Clare, A. W., Mulvany, F., Byrne, M., O’Callaghan, E., Byrne, H., Cannon, N., Kinsella, T., Cassidy, B., Shepard, N., Horgan, R., Larkin, C., Cotter, D., Coffey, V. P., Sham, P. C., Murray, L. H., Lane, A., Kinsella, A., Murphy, P., Colgan, K., Sloan, D., Gilligan, P., McEnri, J., Ennis, J. T., Stack, J., Corcoran, E., Walsh, D., Thornton, L., Temperley, I., Lawlor, E., Tobin, A., Hillary, I., Nelson, H. G., Martin, M., Ryan, F. M., Christie, M. A., Murray, D., Keane, E., Holmes, E., Hollyer, J., Strangeways, J., Foster, P., Stanwell-Smith, R., Griffin, E., Conlon, T., Hayes, E., Clarke, T., Fogarty, J., Moloney, A. C., Killeen, P., Farrell, S., Clancy, L., Hynes, M., Conlon, C., Foley-Nolan, C., Shelley, E., Collins, C., McNamara, E., Hayes, B., Creamer, E., LaFoy, M., Costigan, P., Al fnAnsari, N., Cunney, R. J., Smyth, E. G., Johnson, H., McQuoid, G., Gilmer, B., Browne, G., Keogh, J. A. B., Jefferson, A, Smith, M., Hennessy, S., Burke, C. M., Sreenan, S., Power, C. K., Pathmakanthan, S., Poulter, L. W., Chan, A., Sheehan, M., Maguire, M., O’Connor, C. M., FitzGerald, M. X., Southey, A., Costello, C. M., McQuaid, K., Urbach, V., Thomas, S., Horwitz, E. R., Mulherin, D., FitzGerald, O., Bresnihan, B., Kirk, G., Veale, D. J., Belch, J. J. F., Mofidi, A., Mofidi, R., Quigley, C., McLaren, M., Veale, D., D’Arrigo, C., Couto, J. Candal, Woof, J., Greer, M., Cree, I., Belch, J., Hone, S., Fenton, J., Hamilton, S., and McShane, D.

Published
1994
Full Text
View/download PDF

39. Irish thoracic society: Proceedings of annual scientific meeting held in Cork on 5th & 6th November, 1993

Author

Chan, K. H., Singh, H. P., Aherne, T., Carabine, U., Gilliland, H., Johnston, J. R., Lowry, K. G., McGuigan, J., Cosgrove, J., Veerasingham, D., McCarthy, J., Hurley, J., Wood, A. E., Gilliland, R., McGuigan, J. A., McManus, K. G., Wilkinson, P., Johnston, L. C., MacMahon, J., Wilson, D., Austin, C., Anikin, V., McManus, K., McGuigan, J., McManus, K., Anikin, V., Gibbons, J. R. P., McGuigan, J., Sharkey, R., Long, M., Maree, A., O’Neill, S., Maguire, C. P., Hayes, J. P., Masterson, J., Fitzgerald, M. X., Hayes, M., Maguire, C. P., Hayes, J. P., Masterson, J., Fitzgerald, M. X., Quigley, C., Mofidi, A., Mofidi, R., Fitzgerald, M. X., O’Neill, M., Watson, J. B. G., O’Halloran, E. T., Shortt, C., Taylor, M., Holland, C., O’Lorcain, P., Taylor, M., Holland, C., O’Lorcain, P., Pathmakanthan, S., Sreenan, S., Power, C. K., Poulter, L. W., Burke, C. M., Reilly, D., Pathmakanthan, S., Sreenan, S., Doyle, S., Burke, C. M., Sreenan, S., Power, C., Pathmakanthan, S., Goggin, A., Burke, C. M., Poulter, L. W., Sreenan, S., Doyle, S., Pathmakanthan, S., Poulter, L. W., Burke, C. M., Sreenan, S., Debenham, P., Pathmakanthan, S., Burke, C. M., Poulter, L. W., Southey, A., O’Connor, C. M., Fitzgerald, M. X., Bourke, W. J., McDonnell, T. J., Buck, J. B., Magee, T. R. A., Lowry, R. C., Graham, A. N. J., Owens, W. A., Kelly, S. B., McGuigan, J. A., Costelloe, R. W., Ryan, J., Collins, J., Guerin, D., Rooney, D., Long, E., O’Donnell, M., O’Neill, S., Cotter, T. P., Bredin, C. P., Buick, J. B., Lowry, R. C., MacMahon, J. J., Finlay, G., Concannon, D., McDonnell, T. J., Reid, P. T., Alderdice, J., Carson, J., Sinnamon, D. G., Murphy, S., Scott, T., Keane, C. T., Walsh, J. B., Coakley, D., McKeown, D., Kelly, P., Clancy, L., Kiely, J. L., Cryan, B., Bredin, C. P., Killeen, P., Farrell, S., Kelly, P., Clancy, L., Kiely, J. L., O’Riordan, D. M., Sheehan, S., Curtain, J., Hogan, J., Bredin, C. P., Malone, A., Ahmed, S., Watson, J. B. G., Murphy, M., Fennell, W., Ahmed, S., Watson, J. B. G., Aherne, T., Keohane, C., O’Neill, M., Gleeson, C. M., McGuigan, J., Ritchie, A. J., Russell, S. E. H., Molloy, E., Keane, M., Coakley, R., Costello, R., Condron, C., Watson, R. G. W., O’Neill, S., Kelly, C., Redmond, H., Watson, W., Burke, P., Bouchier-Hayes, D., Donnelly, S. C., Haslett, C., Dransfield, I., Robertson, C. E., Carter, D. C., Ross, J. A., Grant, I. S., Tedder, T. F., Doyle, S., Sreenan, S., Pathmakanthan, S., Burke, C. M., Heaney, L. G., Cross, L. J. M., Stanford, C. F., Ennis, Madeleine, Sreenan, S., Pathmakanthan, S., Power, C., Goggin, A., Poulter, L. W., Burke, C. M., Murphy, S., Scott, T., Keane, C. T., Walsh, J. B., Coakley, D., O’Riordan, D. M., Gergely, L., Deng, N., Rose, R. M., Hennessy, T., Hickey, L., Thornton, L., Collum, C., Durity, M., Power, J., Johnson, H., Lee, B., Doherty, E., Kelly, E., McDonnell, T., McKeown, D., Kelly, P., Clancy, L., Wilkinson, P., Varghese, G., Anikin, V., Gibbons, J., McManus, K., McGuigan, J., Reid, P. T., Gower, N. H., and Rudd, R. M.

Published
1994
Full Text
View/download PDF

40. Irish society for gastroenterology: Abstracts of Poster Presentations presented at the Irish Society for Gastroenterology, James Connolly Memorial Hospital, Blanchardstown on November 26th and 27th, 1993

Author

Mealy, K., Adeyoju, A., O’Nullain, E., Smyth, H., Keane, F. B. V., Reen, D., Tanner, A., Wang, J. H., Redmond, H. P., Watson, R. W. G., Duggen, S., Boucher-Hayes, D., Casey, Mary, Stevens, Fiona M., Bruzzi, J., El-Magbri, A. A., Stevens, F. M., McCarthy, C. F., Egan, L. J., Johnston, J., Walsh, S., Murphy, R. P., O’Gorman, T., Headon, D. R., Connolly, C. E., Johnston, S., Tham, T. C. K., Watson, R. G. P., O’Donnell, L. J. D., Battistini, B., Warner, T. D., Fournier, A., Farthing, M. J. G., Vane, R. J., Skelly, M. M., Mulcahy, H. E., O’Donoghue, D. P., McDermott, E. W. M., Al Khalifa, K., Murphy, J. J., Goggins, M., Mahmud, N., Keeling, P. W. N., Weir, D. C., Kelleher, D., Keogh, I. J., Kerin, M. J., O’Hanlon, D., Kent, P., Callaghan, J., Given, H. F., Buckley, M., Sweeney, K., Xia, H. X., Keane, C. T., O’Morain, C., Farrell, R. J., Khan, M. I., Cherukuri, A. K., Moloney, M., Weir, D. G., Harden, C. A., Boyle, T. J., Condon, F., Stephens, R. B., Berend, K. R., DiMaio, J. M., Coles, R. E., Lyerly, H. K., Abuzakouk, M., Feighery, C., Casey, E., O’Farrelly, C., Meagher, P., Austin, O., Phillips, J., Cleary, A. P., Deasy, J., McKeogh, D., Merriman, R., MacMathuna, P., O’Keane, C., Hone, R., Lennon, J., Crowe, J., Kane, D., McKiernan, M., Mac Mathuna, P., Clarke, E., Kilgallen, C. K., Mooney, E. E., Stephens, R., Sweeney, E., Carroll, T., Stokes, M. A., Regan, M. C., Waldon, D. J., Jonsson, T., Fitzpatrick, J. M., Gorey, T. F., Duggan, M., Mulligan, E., Bannon, C., Morrin, M., Khan, F., Barrett, N., Delaney, P., Todd, A., Madhaven, P., O’Sullivan, R., Durkan, M., Nyhan, T., Lynch, G., Egan, T. J., Delaney, P. V., O’Connell, M., Neary, P., Reid, S., Horgan, P., Shami, J., Traynor, O., Fan, X. G., Chua, A., Fan, X. J., O’ Byrne, K., Khan, I., Farrell, R., Daly, P., Cherukuril, A. K., Farrell, R. I., Maloney, M., Noonan, N., Carey, C., Keane, C., Syed Asad, A., Lane, B., Browne, H. I., Keeling, P., Baldota, S., Madden, C., Johnston, J. G., Waldron, R., Kenny-Walsh, E., Welton, M. J., and Hyland, J.

Published
1994
Full Text
View/download PDF

41. International consensus definition of low anterior resection syndrome

Author

Keane, C, Fearnhead, NS, Bordeianou, L, Christensen, P, Espin Basany, E, Laurberg, S, Mellgren, A, Messick, C, Orangio, GR, Verjee, A, Wing, K, Bissett, I, An, V, Bryant, A, Byrne, C, Chen, T, Clark, D, Croft, S, Dinning, P, Gladman, M, Heriot, A, Kariappa, S, Keck, J, Lubowski, D, Khera, A, Kirkwood, K, Petersen, D, Sloots, K, Totten, B, Weston, M, Andersen, P, Bachmann, C, Barht, H, Emmertsen, K, Faaborg, P, Gögenur, I, Ingerslev, P, Isaksen, D, Iversen, H, Iversen, L, Jacobsen, K, Jansen, T, Jocobsen, I, Juul, T, Kjær, D, Krogh, K, Majgaard, M, Mynster, A, Neuenschwander, A, Nielsen, C, Nielsen, M, Nielsen, R, Nielsen, T, Olsen, J, Poulsen, B, Rahr, H, Snedker, B, Sørensen, G, Stolzenburg, T, Vaabengaard, P, Acheson, A, Andreyev, J, Bach, S, Battersby, N, Bradbury, J, Brown, S, Cecil, T, Chapman, M, Chapman, S, Chave, H, Cook, T, Cuffy, L, Davies, J, Dawson, C, Dixon, J, Duff, S, Edwards, C, Geh, I, Hamilton, C, Hancock, L, Harji, D, Hill, J, Holtham, S, Jenkins, J, Johnston, R, Kapur, S, Maxwell‐Armstrong, C, McArthur, D, Moran, B, Norton, C, Nugent, K, Pateman, L, Perston, Y, Rockall, T, Sagar, P, Saunders, M, Sebag‐Montefiore, D, Senapati, A, Singh, B, Skaife, P, Smart, N, Sykes, H, Taylor, C, Thorpe, G, Tierney, G, Voyce, S, Walsh, C, Warren, O, Wheeler, J, Woodward, A, Winter, D, Abbott, S, Beban, V, Bennett, M, Chadwick, T, Collinson, R, Corbett, S, Dennett, E, Eglinton, T, Fraser, A, Glue, J, Hohaia, D, Menzi, E, O’Connor, M, Stevenson, D, Wells, C, Wolyncewicz, S, Woodfield, J, Bence, K, Boutros, M, Brueseke, M, DeKorte, J, Floruta, C, Francone, T, Frederick, F, Grasso, J, Gurland, B, Higgins, K, Hull, T, Keller, D, Laffan, A, Lovett, S, Marlatt, J, McAdams, D, McCarthy, C, Milch, H, Natale, S, Pappou, E, Paquette, I, Pulskamp, S, Rich, M, Savitt, L, Shafi, M, Steele, S, Stein, S, Tolbert, M, Varma, M, Vogler, S, Vuong, T, Wells, K, Wexner, S, Wo, J, Wright, J, Wunderlich, C, Campbell, K, Lim, M, Moug, S, Oliphant, R, Araujo‐Ferreiro, M, Ballester, C, Belen‐Bueno, A, Blanco‐Colino, R, Carrillo‐Moreno, J, Castillo, J, Codina‐Cazador, A, Enriquez‐Navascuez, JM, Gallego‐García, M, Jerez, J, Jimenez, LM, Labaka‐Aretaga, I, Martin‐Fernández, M, Martinez‐Sanchez, C, Muñoz, A, Paniagua‐Cayetano, G, Pascual‐Damieta, M, de la Portilla, F, Ramirez, L, Sanchez‐García, C, Vaquer‐Casas, G, Vico‐García, E, Vigorita, V, Adams, R, Cornish, J, Davies, M, Evans, M, Torkington, J, and Turner, J

Abstract

Aim: Low anterior resection syndrome (LARS) is pragmatically defined as disordered bowel function after rectal resection leading to a detriment in quality of life. This broad characterization does not allow for precise estimates of prevalence. The LARS score was designed as a simple tool for clinical evaluation of LARS. Although the LARS score has good clinical utility, it may not capture all important aspects that patients may experience. The aim of this collaboration was to develop an international consensus definition of LARS that encompasses all aspects of the condition and is informed by all stakeholders. Method: This international patient–provider initiative used an online Delphi survey, regional patient consultation meetings, and an international consensus meeting. Three expert groups participated: patients, surgeons and other health professionals from five regions (Australasia, Denmark, Spain, Great Britain and Ireland, and North America) and in three languages (English, Spanish, and Danish). The primary outcome measured was the priorities for the definition of LARS. Results: Three hundred twenty-five participants (156 patients) registered. The response rates for successive rounds of the Delphi survey were 86%, 96% and 99%. Eighteen priorities emerged from the Delphi survey. Patient consultation and consensus meetings refined these priorities to eight symptoms and eight consequences that capture essential aspects of the syndrome. Sampling bias may have been present, in particular, in the patient panel because social media was used extensively in recruitment. There was also dominance of the surgical panel at the final consensus meeting despite attempts to mitigate this. Conclusion: This is the first definition of LARS developed with direct input from a large international patient panel. The involvement of patients in all phases has ensured that the definition presented encompasses the vital aspects of the patient experience of LARS. The novel separation of symptoms and consequences may enable greater sensitivity to detect changes in LARS over time and with intervention.

Published
2020

43. International Consensus Definition of Low Anterior Resection Syndrome

Author

Universidad de Sevilla. Departamento de Cirugía, American Society of Colon and Rectal Surgeons (ASCRS), Association of Coloproctology of Great Britain and Ireland (ACPGBI), Auckland Medical Research Foundation, Auckland Medical Research Foundation (AMRF), Auckland Medical Research Foundation Ruth Spencer Fellowship, BDRF, Bowel Disease Research Foundation (BDRF), Colon and Rectal Surgery Section of the Royal Australasian College of Surgeons (RACS), Colorectal Surgical Society of Australia and New Zealand (CSSANZ), Danish Cancer Society, ESCP, European Society of Coloproctology (ESCP), Royal Society of Medicine (RSM) Section of Coloproctology, Keane, C, Fearnhead, NS, Bordeianou, LG, Christensen, Peter, Basany, EE, Laurberg, S, Portilla de Juan, Fernando de la, Bissett, IP, Universidad de Sevilla. Departamento de Cirugía, American Society of Colon and Rectal Surgeons (ASCRS), Association of Coloproctology of Great Britain and Ireland (ACPGBI), Auckland Medical Research Foundation, Auckland Medical Research Foundation (AMRF), Auckland Medical Research Foundation Ruth Spencer Fellowship, BDRF, Bowel Disease Research Foundation (BDRF), Colon and Rectal Surgery Section of the Royal Australasian College of Surgeons (RACS), Colorectal Surgical Society of Australia and New Zealand (CSSANZ), Danish Cancer Society, ESCP, European Society of Coloproctology (ESCP), Royal Society of Medicine (RSM) Section of Coloproctology, Keane, C, Fearnhead, NS, Bordeianou, LG, Christensen, Peter, Basany, EE, Laurberg, S, Portilla de Juan, Fernando de la, and Bissett, IP

Abstract

Aim Low anterior resection syndrome (LARS) is pragmatically defined as disordered bowel function after rectal resection leading to a detriment in quality of life. This broad characterization does not allow for precise estimates of prevalence. The LARS score was designed as a simple tool for clinical evaluation of LARS. Although the LARS score has good clinical utility, it may not capture all important aspects that patients may experience. The aim of this collaboration was to develop an international consensus definition of LARS that encompasses all aspects of the condition and is informed by all stakeholders. Method This international patient–provider initiative used an online Delphi survey, regional patient consultation meetings, and an international consensus meeting. Three expert groups participated: patients, surgeons and other health professionals from five regions (Australasia, Denmark, Spain, Great Britain and Ireland, and North America) and in three languages (English, Spanish, and Danish). The primary outcome measured was the priorities for the definition of LARS. Results Three hundred twenty-five participants (156 patients) registered. The response rates for successive rounds of the Delphi survey were 86%, 96% and 99%. Eighteen priorities emerged from the Delphi survey. Patient consultation and consensus meetings refined these priorities to eight symptoms and eight consequences that capture essential aspects of the syndrome. Sampling bias may have been present, in particular, in the patient panel because social media was used extensively in recruitment. There was also dominance of the surgical panel at the final consensus meeting despite attempts to mitigate this. Conclusion This is the first definition of LARS developed with direct input from a large international patient panel. The involvement of patients in all phases has ensured that the definition presented encompasses the vital aspects of the patient experience of LARS. The novel separation of sympto

Published
2020

45. Irish Society of Gastroenterology: Proceedings of meeting held in Dublin, 7th & 8th June, 1991

Author

Campbell, W. J., Parks, T. G., Spence, R. A. J., Nevin, N. C., Jazrawi, S., Walsh, T. N., Byrne, P. J., Li, H., Hennessy, T. P. J., Hill, A. D. K., Bolger, C., Prendiville, E. J., Corbett, A., O’Sullivan, G., Collins, J. K., O’Sullivan, M., Nolan, S., O’Donoghue, M., O’Donoghue, Brenda, McCabe, D., O’Brien, S., Dowsett, J., Fitzgerald, M. X., Hegarty, J. E., Madrigal, L., Lynch, S., Kelleher, D., Feighery, C., Weir, D. G., O’Farrelly, C., Feighery, C., Weir, D. G., O’Farrelly, C., Meenan, J., Mulcahy, F., Keeling, P. W. N., Mulcahy, H., Patchett, S., Afdhal, N., O’Donoghue, D. P., Toner, M., Daly, I. L., McCarthy, C., Collins, R., Beattie, S., Keane, C., O’Morain, C., McEniff, N., Hamilton, S., O’Donnell, M. D., Nolan, N. P., Foster-Smith, E., McGeeney, K. F., Burke, G., Joyce, W. P., Delaney, P. V., Choo, K. F., Stevens, F. M., Maher, M., Waldron, R., Caldwell, M. T. P., Murchan, P., Beesley, W., Feeley, T. M., Tanner, W. A., Keane, F. V. B., Stokes, M. A., Hill, G. L., O’Connor, H. J., Redmond, P. L., Dickey, W., Watson, R. G. P., Porter, K. G., Xia, H. X., Daw, M. A., Keane, C. T., O’Morain, C. A., Gardiner, K. R., Abderson, N. H., McCaigue, M. D., Erwin, P. J., Halliday, M. I., Rowlands, B. J., Attwood, S. E. A., Mealy, K., McGrath, J., Abbasakoor, F., Stephens, R. B., Nicholson, P., Mealy, K., Hyland, J., Traynor, O., Grosjean, I., O’Brien, F., Irwin, S. T., Barry, M., Mealy, K., Hyland, J., Traynor, O. J., Tan, K. C., Guiney, E. J., O’Grady, J., Williams, R., Attwood, S. E. A., McGrath, J. P., Stephens, R. B., Byrne, J., Timon, D., Armstrong, C., and Quill, D. S.

Published
1991
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results